These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
|
91-1962278
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
|
3003 Tasman Drive, Santa Clara, California
|
|
95054-1191
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
Page
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
|
|
|
|
Item 1.
|
||
|
|
|
|
|
Item 1A.
|
||
|
|
|
|
|
Item 2.
|
||
|
|
|
|
|
Item 3.
|
||
|
|
|
|
|
Item 4.
|
||
|
|
|
|
|
Item 5.
|
||
|
|
|
|
|
Item 6.
|
||
|
|
|
|
|
|
|
|
|
(Dollars in thousands, except par value and share data)
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
Assets
|
|
|
|
|
||||
|
Cash and cash equivalents
|
|
$
|
1,519,249
|
|
|
$
|
1,008,983
|
|
|
Available-for-sale securities
|
|
10,908,163
|
|
|
11,343,177
|
|
||
|
Non-marketable securities
|
|
1,215,788
|
|
|
1,184,265
|
|
||
|
Investment securities
|
|
12,123,951
|
|
|
12,527,442
|
|
||
|
Loans, net of unearned income
|
|
8,844,890
|
|
|
8,946,933
|
|
||
|
Allowance for loan losses
|
|
(112,205
|
)
|
|
(110,651
|
)
|
||
|
Net loans
|
|
8,732,685
|
|
|
8,836,282
|
|
||
|
Premises and equipment, net of accumulated depreciation and amortization
|
|
65,713
|
|
|
66,545
|
|
||
|
Accrued interest receivable and other assets
|
|
354,402
|
|
|
326,871
|
|
||
|
Total assets
|
|
$
|
22,796,000
|
|
|
$
|
22,766,123
|
|
|
Liabilities and total equity
|
|
|
|
|
||||
|
Liabilities:
|
|
|
|
|
||||
|
Noninterest-bearing demand deposits
|
|
$
|
14,038,587
|
|
|
$
|
13,875,275
|
|
|
Interest-bearing deposits
|
|
5,271,321
|
|
|
5,301,177
|
|
||
|
Total deposits
|
|
19,309,908
|
|
|
19,176,452
|
|
||
|
Short-term borrowings
|
|
7,460
|
|
|
166,110
|
|
||
|
Other liabilities
|
|
359,380
|
|
|
360,566
|
|
||
|
Long-term debt
|
|
457,194
|
|
|
457,762
|
|
||
|
Total liabilities
|
|
20,133,942
|
|
|
20,160,890
|
|
||
|
Commitments and contingencies (Note 11 and Note 14)
|
|
|
|
|
|
|||
|
SVBFG stockholders’ equity:
|
|
|
|
|
||||
|
Preferred stock, $0.001 par value, 20,000,000 shares authorized;
no shares issued and outstanding |
|
—
|
|
|
—
|
|
||
|
Common stock, $0.001 par value, 150,000,000 shares authorized; 44,970,402 shares and 44,627,182 shares outstanding, respectively
|
|
45
|
|
|
45
|
|
||
|
Additional paid-in capital
|
|
570,789
|
|
|
547,079
|
|
||
|
Retained earnings
|
|
1,215,770
|
|
|
1,174,878
|
|
||
|
Accumulated other comprehensive income
|
|
95,615
|
|
|
108,553
|
|
||
|
Total SVBFG stockholders’ equity
|
|
1,882,219
|
|
|
1,830,555
|
|
||
|
Noncontrolling interests
|
|
779,839
|
|
|
774,678
|
|
||
|
Total equity
|
|
2,662,058
|
|
|
2,605,233
|
|
||
|
Total liabilities and total equity
|
|
$
|
22,796,000
|
|
|
$
|
22,766,123
|
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands, except per share amounts)
|
|
2013
|
|
2012
|
||||
|
Interest income:
|
|
|
|
|
||||
|
Loans
|
|
$
|
123,744
|
|
|
$
|
109,461
|
|
|
Available-for-sale securities:
|
|
|
|
|
||||
|
Taxable
|
|
45,752
|
|
|
47,375
|
|
||
|
Non-taxable
|
|
799
|
|
|
900
|
|
||
|
Federal funds sold, securities purchased under agreements to resell and other short-term investment securities
|
|
719
|
|
|
1,038
|
|
||
|
Total interest income
|
|
171,014
|
|
|
158,774
|
|
||
|
Interest expense:
|
|
|
|
|
||||
|
Deposits
|
|
2,051
|
|
|
1,481
|
|
||
|
Borrowings
|
|
5,794
|
|
|
6,356
|
|
||
|
Total interest expense
|
|
7,845
|
|
|
7,837
|
|
||
|
Net interest income
|
|
163,169
|
|
|
150,937
|
|
||
|
Provision for loan losses
|
|
5,813
|
|
|
14,529
|
|
||
|
Net interest income after provision for loan losses
|
|
157,356
|
|
|
136,408
|
|
||
|
Noninterest income:
|
|
|
|
|
||||
|
Gains on investment securities, net (includes losses of $45 and $874, respectively, in unrealized net losses on available-for-sale securities reclassified out of AOCI)
|
|
27,438
|
|
|
7,839
|
|
||
|
Foreign exchange fees
|
|
13,448
|
|
|
12,103
|
|
||
|
Gains on derivative instruments, net
|
|
11,040
|
|
|
5,976
|
|
||
|
Deposit service charges
|
|
8,793
|
|
|
8,096
|
|
||
|
Credit card fees
|
|
7,448
|
|
|
5,668
|
|
||
|
Client investment fees
|
|
3,475
|
|
|
2,897
|
|
||
|
Letters of credit and standby letters of credit income
|
|
3,435
|
|
|
3,636
|
|
||
|
Other
|
|
3,527
|
|
|
13,078
|
|
||
|
Total noninterest income
|
|
78,604
|
|
|
59,293
|
|
||
|
Noninterest expense:
|
|
|
|
|
||||
|
Compensation and benefits
|
|
88,704
|
|
|
83,737
|
|
||
|
Professional services
|
|
17,160
|
|
|
14,607
|
|
||
|
Premises and equipment
|
|
10,725
|
|
|
7,564
|
|
||
|
Business development and travel
|
|
8,272
|
|
|
7,746
|
|
||
|
Net occupancy
|
|
5,767
|
|
|
5,623
|
|
||
|
FDIC assessments
|
|
3,382
|
|
|
2,498
|
|
||
|
Correspondent bank fees
|
|
3,055
|
|
|
2,688
|
|
||
|
Provision for (reduction of) unfunded credit commitments
|
|
2,014
|
|
|
(258
|
)
|
||
|
Other
|
|
9,935
|
|
|
7,807
|
|
||
|
Total noninterest expense
|
|
149,014
|
|
|
132,012
|
|
||
|
Income before income tax expense
|
|
86,946
|
|
|
63,689
|
|
||
|
Income tax expense (includes income tax benefits of $18 and $357, respectively, from AOCI reclassification items)
|
|
26,401
|
|
|
23,756
|
|
||
|
Net income before noncontrolling interests
|
|
60,545
|
|
|
39,933
|
|
||
|
Net income attributable to noncontrolling interests
|
|
(19,654
|
)
|
|
(5,143
|
)
|
||
|
Net income available to common stockholders
|
|
$
|
40,891
|
|
|
$
|
34,790
|
|
|
Earnings per common share—basic
|
|
$
|
0.91
|
|
|
$
|
0.79
|
|
|
Earnings per common share—diluted
|
|
0.90
|
|
|
0.78
|
|
||
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Net income before noncontrolling interests
|
|
$
|
60,545
|
|
|
$
|
39,933
|
|
|
Other comprehensive income, net of tax:
|
|
|
|
|
||||
|
Change in cumulative translation gains:
|
|
|
|
|
||||
|
Foreign currency translation (losses) gains
|
|
(826
|
)
|
|
2,472
|
|
||
|
Related tax benefit (expense)
|
|
297
|
|
|
(1,013
|
)
|
||
|
Change in unrealized (losses) gains on available-for-sale securities:
|
|
|
|
|
||||
|
Unrealized holding (losses) gains
|
|
(22,102
|
)
|
|
3,269
|
|
||
|
Related tax benefit (expense)
|
|
9,666
|
|
|
(1,335
|
)
|
||
|
Reclassification adjustment for losses included in net income
|
|
45
|
|
|
874
|
|
||
|
Related tax benefit
|
|
(18
|
)
|
|
(357
|
)
|
||
|
Other comprehensive (losses) income, net of tax
|
|
(12,938
|
)
|
|
3,910
|
|
||
|
Comprehensive income
|
|
47,607
|
|
|
43,843
|
|
||
|
Comprehensive income attributable to noncontrolling interests
|
|
(19,654
|
)
|
|
(5,143
|
)
|
||
|
Comprehensive income attributable to SVBFG
|
|
$
|
27,953
|
|
|
$
|
38,700
|
|
|
|
|
Common Stock
|
|
Additional
Paid-in Capital
|
|
Retained Earnings
|
|
Accumulated
Other
Comprehensive Income
|
|
Total SVBFG
Stockholders’ Equity
|
|
Noncontrolling Interests
|
|
Total Equity
|
|||||||||||||||||
|
(Dollars in thousands)
|
|
Shares
|
|
Amount
|
|
|
|
|
|
|
|||||||||||||||||||||
|
Balance at December 31, 2011
|
|
43,507,932
|
|
$
|
44
|
|
|
$
|
484,216
|
|
|
$
|
999,733
|
|
|
$
|
85,399
|
|
|
$
|
1,569,392
|
|
|
$
|
680,997
|
|
|
$
|
2,250,389
|
|
|
|
Common stock issued under employee benefit plans, net of restricted stock cancellations
|
|
505,618
|
|
—
|
|
|
17,900
|
|
|
—
|
|
|
—
|
|
|
17,900
|
|
|
—
|
|
|
17,900
|
|
||||||||
|
Common stock issued under ESOP
|
|
73,560
|
|
—
|
|
|
4,345
|
|
|
—
|
|
|
—
|
|
|
4,345
|
|
|
—
|
|
|
4,345
|
|
||||||||
|
Income tax benefit from stock options exercised, vesting of restricted stock and other
|
|
—
|
|
—
|
|
|
3,819
|
|
|
—
|
|
|
—
|
|
|
3,819
|
|
|
—
|
|
|
3,819
|
|
||||||||
|
Net income
|
|
—
|
|
—
|
|
|
—
|
|
|
34,790
|
|
|
—
|
|
|
34,790
|
|
|
5,143
|
|
|
39,933
|
|
||||||||
|
Capital calls and distributions, net
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
17,073
|
|
|
17,073
|
|
||||||||
|
Net change in unrealized gains on available-for-sale securities, net of tax
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,451
|
|
|
2,451
|
|
|
—
|
|
|
2,451
|
|
||||||||
|
Foreign currency translation adjustments, net of tax
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,459
|
|
|
1,459
|
|
|
—
|
|
|
1,459
|
|
||||||||
|
Share-based compensation expense
|
|
—
|
|
—
|
|
|
5,334
|
|
|
—
|
|
|
—
|
|
|
5,334
|
|
|
—
|
|
|
5,334
|
|
||||||||
|
Balance at March 31, 2012
|
|
44,087,110
|
|
$
|
44
|
|
|
$
|
515,614
|
|
|
$
|
1,034,523
|
|
|
$
|
89,309
|
|
|
$
|
1,639,490
|
|
|
$
|
703,213
|
|
|
$
|
2,342,703
|
|
|
|
Balance at December 31, 2012
|
|
44,627,182
|
|
$
|
45
|
|
|
$
|
547,079
|
|
|
$
|
1,174,878
|
|
|
$
|
108,553
|
|
|
$
|
1,830,555
|
|
|
$
|
774,678
|
|
|
$
|
2,605,233
|
|
|
|
Common stock issued under employee benefit plans, net of restricted stock cancellations
|
|
268,274
|
|
—
|
|
|
12,895
|
|
|
—
|
|
|
—
|
|
|
12,895
|
|
|
—
|
|
|
12,895
|
|
||||||||
|
Common stock issued under ESOP
|
|
74,946
|
|
—
|
|
|
5,166
|
|
|
—
|
|
|
—
|
|
|
5,166
|
|
|
—
|
|
|
5,166
|
|
||||||||
|
Income tax expense from stock options exercised, vesting of restricted stock and other
|
|
—
|
|
—
|
|
|
(637
|
)
|
|
—
|
|
|
—
|
|
|
(637
|
)
|
|
—
|
|
|
(637
|
)
|
||||||||
|
Net income
|
|
—
|
|
—
|
|
|
—
|
|
|
40,891
|
|
|
—
|
|
|
40,891
|
|
|
19,654
|
|
|
60,545
|
|
||||||||
|
Capital calls and (distributions), net
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(14,493
|
)
|
|
(14,493
|
)
|
||||||||
|
Net change in unrealized gains on available-for-sale securities, net of tax
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(12,409
|
)
|
|
(12,409
|
)
|
|
—
|
|
|
(12,409
|
)
|
||||||||
|
Foreign currency translation adjustments, net of tax
|
|
—
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(529
|
)
|
|
(529
|
)
|
|
—
|
|
|
(529
|
)
|
||||||||
|
Share-based compensation expense
|
|
—
|
|
—
|
|
|
6,286
|
|
|
—
|
|
|
—
|
|
|
6,286
|
|
|
—
|
|
|
6,286
|
|
||||||||
|
Other, net
|
|
—
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
1
|
|
||||||||
|
Balance at March 31, 2013
|
|
44,970,402
|
|
|
$
|
45
|
|
|
$
|
570,789
|
|
|
$
|
1,215,770
|
|
|
$
|
95,615
|
|
|
$
|
1,882,219
|
|
|
$
|
779,839
|
|
|
$
|
2,662,058
|
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Cash flows from operating activities:
|
|
|
|
|
||||
|
Net income before noncontrolling interests
|
|
$
|
60,545
|
|
|
$
|
39,933
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
|
||||
|
Provision for loan losses
|
|
5,813
|
|
|
14,529
|
|
||
|
Provision for (reduction of) unfunded credit commitments
|
|
2,014
|
|
|
(258
|
)
|
||
|
Changes in fair values of derivatives, net
|
|
757
|
|
|
(3,370
|
)
|
||
|
Gains on investment securities, net
|
|
(27,438
|
)
|
|
(7,839
|
)
|
||
|
Depreciation and amortization
|
|
8,479
|
|
|
6,454
|
|
||
|
Amortization of premiums and discounts on available-for-sale securities, net
|
|
8,348
|
|
|
9,869
|
|
||
|
Tax (expense) benefit from stock exercises
|
|
(1,247
|
)
|
|
790
|
|
||
|
Amortization of share-based compensation
|
|
5,826
|
|
|
5,149
|
|
||
|
Amortization of deferred loan fees
|
|
(15,040
|
)
|
|
(15,488
|
)
|
||
|
Deferred income tax expense
|
|
(19
|
)
|
|
(1,570
|
)
|
||
|
Losses from the write-off of premises and equipment
|
|
363
|
|
|
—
|
|
||
|
Changes in other assets and liabilities:
|
|
|
|
|
||||
|
Accrued interest receivable and payable, net
|
|
(4,735
|
)
|
|
(6,399
|
)
|
||
|
Accounts receivable and payable, net
|
|
6,220
|
|
|
14,631
|
|
||
|
Income tax payable and receivable, net
|
|
6,236
|
|
|
14,013
|
|
||
|
Accrued compensation
|
|
(62,375
|
)
|
|
(66,240
|
)
|
||
|
Foreign exchange spot contracts, net
|
|
26,534
|
|
|
(21,154
|
)
|
||
|
Other, net
|
|
(21,325
|
)
|
|
6,078
|
|
||
|
Net cash used for operating activities
|
|
(1,044
|
)
|
|
(10,872
|
)
|
||
|
Cash flows from investing activities:
|
|
|
|
|
||||
|
Purchases of available-for-sale securities
|
|
(219,987
|
)
|
|
(1,777,958
|
)
|
||
|
Proceeds from sales of available-for-sale securities
|
|
581
|
|
|
3,219
|
|
||
|
Proceeds from maturities and pay downs of available-for-sale securities
|
|
653,764
|
|
|
777,717
|
|
||
|
Purchases of nonmarketable securities (cost and equity method accounting)
|
|
(5,112
|
)
|
|
(9,005
|
)
|
||
|
Proceeds from sales of nonmarketable securities (cost and equity method accounting)
|
|
7,942
|
|
|
11,317
|
|
||
|
Purchases of nonmarketable securities (fair value accounting)
|
|
(30,342
|
)
|
|
(29,440
|
)
|
||
|
Proceeds from sales and distributions of nonmarketable securities (fair value accounting)
|
|
21,748
|
|
|
25,545
|
|
||
|
Net decrease (increase) in loans
|
|
108,971
|
|
|
(144,957
|
)
|
||
|
Proceeds from recoveries of charged-off loans
|
|
1,367
|
|
|
3,436
|
|
||
|
Purchases of premises and equipment
|
|
(6,606
|
)
|
|
(8,054
|
)
|
||
|
Net cash provided by (used for) investing activities
|
|
532,326
|
|
|
(1,148,180
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
|
||||
|
Net increase in deposits
|
|
133,456
|
|
|
7,346
|
|
||
|
(Decrease) increase in short-term borrowings
|
|
(158,650
|
)
|
|
849,380
|
|
||
|
Capital contributions from noncontrolling interests, net of distributions
|
|
(14,493
|
)
|
|
17,073
|
|
||
|
Tax benefit from stock exercises
|
|
610
|
|
|
3,029
|
|
||
|
Proceeds from issuance of common stock and ESPP
|
|
18,061
|
|
|
17,900
|
|
||
|
Net cash (used for) provided by financing activities
|
|
(21,016
|
)
|
|
894,728
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
|
510,266
|
|
|
(264,324
|
)
|
||
|
Cash and cash equivalents at beginning of period
|
|
1,008,983
|
|
|
1,114,948
|
|
||
|
Cash and cash equivalents at end of period
|
|
$
|
1,519,249
|
|
|
$
|
850,624
|
|
|
Supplemental disclosures:
|
|
|
|
|
||||
|
Cash paid during the period for:
|
|
|
|
|
||||
|
Interest
|
|
$
|
12,372
|
|
|
$
|
12,012
|
|
|
Income taxes
|
|
19,318
|
|
|
6,556
|
|
||
|
Noncash items during the period:
|
|
|
|
|
||||
|
Unrealized (losses) gains on available-for-sale securities, net of tax
|
|
$
|
(12,409
|
)
|
|
$
|
2,451
|
|
|
1.
|
Basis of Presentation
|
|
1.
|
We have the power to direct the activities of the VIE that most significantly impact the entity’s economic performance;
|
|
2.
|
The aggregate indirect and direct variable interests held by the Company have the obligation to absorb losses or the right to receive benefits from the entity that could be significant to the VIE; and,
|
|
3.
|
Qualitative and quantitative factors regarding the nature, size, and form of our involvement with the VIE.
|
|
2.
|
Stockholders’ Equity and EPS
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars and shares in thousands, except per share amounts)
|
|
2013
|
|
2012
|
||||
|
Numerator:
|
|
|
|
|
||||
|
Net income available to common stockholders
|
|
$
|
40,891
|
|
|
$
|
34,790
|
|
|
Denominator:
|
|
|
|
|
||||
|
Weighted average common shares outstanding-basic
|
|
44,802
|
|
|
43,780
|
|
||
|
Weighted average effect of dilutive securities:
|
|
|
|
|
||||
|
Stock options and ESPP
|
|
402
|
|
|
501
|
|
||
|
Restricted stock units
|
|
189
|
|
|
179
|
|
||
|
Denominator for diluted calculation
|
|
45,393
|
|
|
44,460
|
|
||
|
Earnings per common share:
|
|
|
|
|
||||
|
Basic
|
|
$
|
0.91
|
|
|
$
|
0.79
|
|
|
Diluted
|
|
$
|
0.90
|
|
|
$
|
0.78
|
|
|
|
|
Three months ended March 31,
|
||||
|
(Shares in thousands)
|
|
2013
|
|
2012
|
||
|
Stock options
|
|
708
|
|
|
121
|
|
|
Restricted stock units
|
|
—
|
|
|
1
|
|
|
Total
|
|
708
|
|
|
122
|
|
|
3.
|
Share-Based Compensation
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Share-based compensation expense
|
|
$
|
5,826
|
|
|
$
|
5,149
|
|
|
Income tax benefit related to share-based compensation expense
|
|
(1,603
|
)
|
|
(1,199
|
)
|
||
|
(Dollars in thousands)
|
|
Unrecognized
Expense
|
|
Average
Expected
Recognition
Period - in Years
|
||
|
Stock options
|
|
$
|
13,646
|
|
|
2.43
|
|
Restricted stock units
|
|
21,643
|
|
|
2.51
|
|
|
Total unrecognized share-based compensation expense
|
|
$
|
35,289
|
|
|
|
|
|
|
Options
|
|
Weighted
Average
Exercise Price
|
|
Weighted
Average
Remaining
Contractual
Life in Years
|
|
Aggregate
Intrinsic Value
of In-The-
Money
Options
|
|||||
|
Outstanding at December 31, 2012
|
|
2,060,413
|
|
|
$
|
49.15
|
|
|
|
|
|
||
|
Granted
|
|
—
|
|
|
—
|
|
|
|
|
|
|||
|
Exercised
|
|
(265,814
|
)
|
|
48.53
|
|
|
|
|
|
|||
|
Forfeited
|
|
(8,769
|
)
|
|
52.95
|
|
|
|
|
|
|||
|
Expired
|
|
(200
|
)
|
|
46.48
|
|
|
|
|
|
|||
|
Outstanding at March 31, 2013
|
|
1,785,630
|
|
|
49.22
|
|
|
4.05
|
|
$
|
38,785,843
|
|
|
|
Vested and expected to vest at March 31, 2013
|
|
1,725,072
|
|
|
48.84
|
|
|
4.00
|
|
38,116,691
|
|
||
|
Exercisable at March 31, 2013
|
|
831,168
|
|
|
43.23
|
|
|
2.89
|
|
23,032,874
|
|
||
|
|
|
Shares
|
|
Weighted
Average
Grant Date Fair
Value
|
|||
|
Nonvested at December 31, 2012
|
|
585,543
|
|
|
$
|
59.42
|
|
|
Granted
|
|
3,700
|
|
|
60.92
|
|
|
|
Vested
|
|
(4,228
|
)
|
|
47.89
|
|
|
|
Forfeited
|
|
(3,334
|
)
|
|
57.97
|
|
|
|
Nonvested at March 31, 2013
|
|
581,681
|
|
|
59.52
|
|
|
|
4.
|
Cash and Cash Equivalents
|
|
(Dollars in thousands)
|
|
March 31, 2013
|
|
December 31, 2012
|
||||
|
Cash and due from banks (1)
|
|
$
|
1,144,926
|
|
|
$
|
752,056
|
|
|
Securities purchased under agreements to resell (2)
|
|
338,687
|
|
|
133,357
|
|
||
|
Other short-term investment securities
|
|
35,636
|
|
|
123,570
|
|
||
|
Total cash and cash equivalents
|
|
$
|
1,519,249
|
|
|
$
|
1,008,983
|
|
|
|
|
(1)
|
At
March 31, 2013
and
December 31, 2012
,
$634 million
and
$72 million
, respectively, of our cash and due from banks was deposited at the FRB and was earning interest at the Federal Funds target rate, and interest-earning deposits in other financial institutions were
$213 million
and
$283 million
, respectively.
|
|
(2)
|
At
March 31, 2013
and
December 31, 2012
, securities purchased under agreements to resell were collateralized by U.S. treasury securities and U.S. agency securities with aggregate fair values of
$345 million
and
$136 million
, respectively. None of these securities received as collateral were sold or repledged as of
March 31, 2013
or
December 31, 2012
.
|
|
5.
|
Investment Securities
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||||||||||||||||||||
|
(Dollars in thousands)
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Carrying
Value
|
|
Amortized
Cost
|
|
Unrealized
Gains
|
|
Unrealized
Losses
|
|
Carrying
Value
|
||||||||||||||||
|
Available-for-sale securities, at fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
U.S. treasury securities
|
|
$
|
99,993
|
|
|
$
|
53
|
|
|
$
|
—
|
|
|
$
|
100,046
|
|
|
$
|
25,057
|
|
|
$
|
190
|
|
|
$
|
—
|
|
|
$
|
25,247
|
|
|
U.S. agency debentures
|
|
3,415,170
|
|
|
69,116
|
|
|
(383
|
)
|
|
3,483,903
|
|
|
3,370,455
|
|
|
77,173
|
|
|
—
|
|
|
3,447,628
|
|
||||||||
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Agency-issued mortgage-backed securities
|
|
1,308,099
|
|
|
40,177
|
|
|
(446
|
)
|
|
1,347,830
|
|
|
1,428,682
|
|
|
44,858
|
|
|
(107
|
)
|
|
1,473,433
|
|
||||||||
|
Agency-issued collateralized mortgage obligations—fixed rate
|
|
3,818,389
|
|
|
38,200
|
|
|
(1,522
|
)
|
|
3,855,067
|
|
|
4,063,020
|
|
|
41,949
|
|
|
(995
|
)
|
|
4,103,974
|
|
||||||||
|
Agency-issued collateralized mortgage obligations—variable rate
|
|
1,593,456
|
|
|
9,425
|
|
|
(28
|
)
|
|
1,602,853
|
|
|
1,760,551
|
|
|
12,201
|
|
|
(4
|
)
|
|
1,772,748
|
|
||||||||
|
Agency-issued commercial mortgage-backed securities
|
|
414,300
|
|
|
6,275
|
|
|
(1,240
|
)
|
|
419,335
|
|
|
416,487
|
|
|
6,100
|
|
|
(489
|
)
|
|
422,098
|
|
||||||||
|
Municipal bonds and notes
|
|
83,299
|
|
|
7,204
|
|
|
—
|
|
|
90,503
|
|
|
85,790
|
|
|
7,750
|
|
|
(11
|
)
|
|
93,529
|
|
||||||||
|
Equity securities
|
|
6,486
|
|
|
3,219
|
|
|
(1,079
|
)
|
|
8,626
|
|
|
2,108
|
|
|
2,739
|
|
|
(327
|
)
|
|
4,520
|
|
||||||||
|
Total available-for-sale securities
|
|
$
|
10,739,192
|
|
|
$
|
173,669
|
|
|
$
|
(4,698
|
)
|
|
$
|
10,908,163
|
|
|
$
|
11,152,150
|
|
|
$
|
192,960
|
|
|
$
|
(1,933
|
)
|
|
$
|
11,343,177
|
|
|
Non-marketable securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Venture capital and private equity fund investments (1)
|
|
|
|
|
|
|
|
701,076
|
|
|
|
|
|
|
|
|
665,921
|
|
||||||||||||||
|
Other venture capital investments (2)
|
|
|
|
|
|
|
|
124,786
|
|
|
|
|
|
|
|
|
127,091
|
|
||||||||||||||
|
Non-marketable securities (equity method accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Other investments (3)
|
|
|
|
|
|
|
|
140,607
|
|
|
|
|
|
|
|
|
139,330
|
|
||||||||||||||
|
Low income housing tax credit funds
|
|
|
|
|
|
|
|
69,263
|
|
|
|
|
|
|
|
|
70,318
|
|
||||||||||||||
|
Non-marketable securities (cost method accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Venture capital and private equity fund investments (4)
|
|
|
|
|
|
|
|
160,870
|
|
|
|
|
|
|
|
|
161,884
|
|
||||||||||||||
|
Other investments
|
|
|
|
|
|
|
|
19,186
|
|
|
|
|
|
|
|
|
19,721
|
|
||||||||||||||
|
Total non-marketable securities
|
|
|
|
|
|
|
|
1,215,788
|
|
|
|
|
|
|
|
|
1,184,265
|
|
||||||||||||||
|
Total investment securities
|
|
|
|
|
|
|
|
$
|
12,123,951
|
|
|
|
|
|
|
|
|
$
|
12,527,442
|
|
||||||||||||
|
|
|
(1)
|
The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and our ownership percentage of each fund at
March 31, 2013
and
December 31, 2012
(fair value accounting):
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||
|
(Dollars in thousands)
|
|
Amount
|
|
Ownership %
|
|
Amount
|
|
Ownership %
|
||||||
|
SVB Strategic Investors Fund, LP
|
|
$
|
32,142
|
|
|
12.6
|
%
|
|
$
|
32,850
|
|
|
12.6
|
%
|
|
SVB Strategic Investors Fund II, LP
|
|
92,834
|
|
|
8.6
|
|
|
91,294
|
|
|
8.6
|
|
||
|
SVB Strategic Investors Fund III, LP
|
|
212,392
|
|
|
5.9
|
|
|
209,696
|
|
|
5.9
|
|
||
|
SVB Strategic Investors Fund IV, LP
|
|
189,369
|
|
|
5.0
|
|
|
169,931
|
|
|
5.0
|
|
||
|
Strategic Investors Fund V Funds
|
|
51,985
|
|
|
Various
|
|
|
40,622
|
|
|
Various
|
|
||
|
SVB Capital Preferred Return Fund, LP
|
|
54,919
|
|
|
20.0
|
|
|
53,643
|
|
|
20.0
|
|
||
|
SVB Capital—NT Growth Partners, LP
|
|
59,835
|
|
|
33.0
|
|
|
60,120
|
|
|
33.0
|
|
||
|
SVB Capital Partners II, LP (i)
|
|
1,138
|
|
|
5.1
|
|
|
1,303
|
|
|
5.1
|
|
||
|
Other private equity fund (ii)
|
|
6,462
|
|
|
58.2
|
|
|
6,462
|
|
|
58.2
|
|
||
|
Total venture capital and private equity fund investments
|
|
$
|
701,076
|
|
|
|
|
$
|
665,921
|
|
|
|
||
|
|
|
(i)
|
At
March 31, 2013
, we had a direct ownership interest of
1.3 percent
and an indirect ownership interest of
3.8 percent
in the fund through our ownership interest of SVB Strategic Investors Fund II, LP.
|
|
(ii)
|
At
March 31, 2013
, we had a direct ownership interest of
41.5 percent
and indirect ownership interests of
12.6 percent
and
4.1 percent
in the fund through our ownership interest of SVB Capital—NT Growth Partners, LP and SVB Capital Preferred Return Fund, LP, respectively.
|
|
(2)
|
The following table shows the amounts of other venture capital investments held by the following consolidated funds and our ownership percentage of each fund at
March 31, 2013
and
December 31, 2012
(fair value accounting):
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||
|
(Dollars in thousands)
|
|
Amount
|
|
Ownership %
|
|
Amount
|
|
Ownership %
|
||||||
|
Silicon Valley BancVentures, LP
|
|
$
|
39,971
|
|
|
10.7
|
%
|
|
$
|
43,493
|
|
|
10.7
|
%
|
|
SVB Capital Partners II, LP (i)
|
|
80,966
|
|
|
5.1
|
|
|
79,761
|
|
|
5.1
|
|
||
|
SVB Capital Shanghai Yangpu Venture Capital Fund
|
|
3,849
|
|
|
6.8
|
|
|
3,837
|
|
|
6.8
|
|
||
|
Total other venture capital investments
|
|
$
|
124,786
|
|
|
|
|
$
|
127,091
|
|
|
|
||
|
|
|
(i)
|
At
March 31, 2013
, we had a direct ownership interest of
1.3 percent
and an indirect ownership interest of
3.8 percent
in the fund through our ownership of SVB Strategic Investors Fund II, LP.
|
|
(3)
|
The following table shows the carrying value and our ownership percentage of each investment at
March 31, 2013
and
December 31, 2012
(equity method accounting):
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||
|
(Dollars in thousands)
|
|
Amount
|
|
Ownership %
|
|
Amount
|
|
Ownership %
|
||||||
|
Gold Hill Venture Lending 03, LP (i)
|
|
$
|
11,794
|
|
|
9.3
|
%
|
|
$
|
9,413
|
|
|
9.3
|
%
|
|
Gold Hill Capital 2008, LP (ii)
|
|
20,047
|
|
|
15.5
|
|
|
20,893
|
|
|
15.5
|
|
||
|
China Joint Venture investment
|
|
79,210
|
|
|
50.0
|
|
|
78,545
|
|
|
50.0
|
|
||
|
Other investments
|
|
29,556
|
|
|
Various
|
|
|
30,479
|
|
|
Various
|
|
||
|
Total other investments (equity method accounting)
|
|
$
|
140,607
|
|
|
|
|
$
|
139,330
|
|
|
|
||
|
|
|
(i)
|
At
March 31, 2013
, we had a direct ownership interest of
4.8 percent
in the fund and an indirect interest in the fund through our investment in Gold Hill Venture Lending Partners 03, LLC (“GHLLC”) of
4.5 percent
.
|
|
(ii)
|
At
March 31, 2013
, we had a direct ownership interest of
11.5 percent
in the fund and an indirect interest in the fund through our investment in Gold Hill Capital 2008, LLC of
4.0 percent
.
|
|
(4)
|
Represents investments in
309
and
324
funds (primarily venture capital funds) at
March 31, 2013
and
December 31, 2012
, respectively, where our ownership interest is less than
5%
of the voting interests of each such fund and in which we do not have the ability to exercise significant influence over the partnerships operating activities and financial policies. For the three months ended
March 31, 2013
, we recognized OTTI losses of
$0.5 million
resulting from other-than-temporary declines in value for
16
of the
309
investments. The OTTI losses are included in net gains on investment securities, a component of noninterest income. We concluded that any declines in value for the remaining investments were temporary and as such, no OTTI was required to be recognized. At
March 31, 2013
, the carrying value of these venture capital and private equity fund investments (cost method accounting) was
$161 million
, and the estimated fair value was
$200 million
.
|
|
|
|
March 31, 2013
|
||||||||||||||||||||||
|
|
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
|
(Dollars in thousands)
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
||||||||||||
|
U.S. agency debentures
|
|
$
|
303,265
|
|
|
$
|
(383
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
303,265
|
|
|
$
|
(383
|
)
|
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Agency-issued mortgage-backed securities
|
|
22,351
|
|
|
(446
|
)
|
|
—
|
|
|
—
|
|
|
22,351
|
|
|
(446
|
)
|
||||||
|
Agency-issued collateralized mortgage obligations—fixed rate
|
|
252,341
|
|
|
(1,021
|
)
|
|
95,676
|
|
|
(501
|
)
|
|
348,017
|
|
|
(1,522
|
)
|
||||||
|
Agency-issued collateralized mortgage obligations—variable rate
|
|
—
|
|
|
—
|
|
|
5,239
|
|
|
(28
|
)
|
|
5,239
|
|
|
(28
|
)
|
||||||
|
Agency-issued commercial mortgage-backed securities
|
|
99,554
|
|
|
(1,240
|
)
|
|
—
|
|
|
—
|
|
|
99,554
|
|
|
(1,240
|
)
|
||||||
|
Equity securities
|
|
2,815
|
|
|
(866
|
)
|
|
309
|
|
|
(213
|
)
|
|
3,124
|
|
|
(1,079
|
)
|
||||||
|
Total temporarily impaired securities (1)
|
|
$
|
680,326
|
|
|
$
|
(3,956
|
)
|
|
$
|
101,224
|
|
|
$
|
(742
|
)
|
|
$
|
781,550
|
|
|
$
|
(4,698
|
)
|
|
|
|
(1)
|
As of
March 31, 2013
, we identified a total of
39
investments that were in unrealized loss positions, of which
9
investments totaling
$101.2 million
with unrealized losses of
$0.7 million
have been in an impaired position for a period of time greater than 12 months. As of
March 31, 2013
, we do not intend to sell any impaired debt or equity securities prior to recovery of our adjusted cost basis, and it is more likely than not that we will not be required to sell any of our securities prior to recovery of our adjusted cost basis. Based on our analysis as of
March 31, 2013
, we deem all impairments to be temporary, and therefore changes in value for our temporarily impaired securities as of the same date are included in other comprehensive income. Market valuations and impairment analyses on assets in the available-for-sale securities portfolio are reviewed and monitored on a quarterly basis.
|
|
|
|
December 31, 2012
|
||||||||||||||||||||||
|
|
|
Less than 12 months
|
|
12 months or longer
|
|
Total
|
||||||||||||||||||
|
(Dollars in thousands)
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
|
Fair Value of
Investments
|
|
Unrealized
Losses
|
||||||||||||
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Agency-issued mortgage-backed securities
|
|
$
|
22,831
|
|
|
$
|
(107
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
22,831
|
|
|
$
|
(107
|
)
|
|
Agency-issued collateralized mortgage obligations—fixed rate
|
|
461,397
|
|
|
(995
|
)
|
|
—
|
|
|
—
|
|
|
461,397
|
|
|
(995
|
)
|
||||||
|
Agency-issued collateralized mortgage obligations—variable rate
|
|
—
|
|
|
—
|
|
|
7,908
|
|
|
(4
|
)
|
|
7,908
|
|
|
(4
|
)
|
||||||
|
Agency-issued commercial mortgage-backed securities
|
|
150,581
|
|
|
(489
|
)
|
|
—
|
|
|
—
|
|
|
150,581
|
|
|
(489
|
)
|
||||||
|
Municipal bonds and notes
|
|
2,098
|
|
|
(11
|
)
|
|
—
|
|
|
—
|
|
|
2,098
|
|
|
(11
|
)
|
||||||
|
Equity securities
|
|
97
|
|
|
(61
|
)
|
|
255
|
|
|
(266
|
)
|
|
352
|
|
|
(327
|
)
|
||||||
|
Total temporarily impaired securities
|
|
$
|
637,004
|
|
|
$
|
(1,663
|
)
|
|
$
|
8,163
|
|
|
$
|
(270
|
)
|
|
$
|
645,167
|
|
|
$
|
(1,933
|
)
|
|
|
|
March 31, 2013
|
|||||||||||||||||||||||||||||||||
|
|
|
Total
|
|
One Year
or Less
|
|
After One
Year to
Five Years
|
|
After Five
Years to
Ten Years
|
|
After
Ten Years
|
|||||||||||||||||||||||||
|
(Dollars in thousands)
|
|
Carrying
Value
|
|
Weighted-
Average
Yield
|
|
Carrying
Value
|
|
Weighted-
Average
Yield
|
|
Carrying
Value
|
|
Weighted-
Average
Yield
|
|
Carrying
Value
|
|
Weighted-
Average
Yield
|
|
Carrying
Value
|
|
Weighted-
Average
Yield
|
|||||||||||||||
|
U.S. treasury securities
|
|
$
|
100,046
|
|
|
0.68
|
%
|
|
$
|
100,046
|
|
|
0.68
|
%
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
%
|
|
$
|
—
|
|
|
—
|
%
|
|
U.S. agency debentures
|
|
3,483,903
|
|
|
1.54
|
|
|
151,367
|
|
|
1.30
|
|
|
2,584,574
|
|
|
1.48
|
|
|
747,962
|
|
|
1.76
|
|
|
—
|
|
|
—
|
|
|||||
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
|
Agency-issued mortgage-backed securities
|
|
1,347,830
|
|
|
2.32
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,228,081
|
|
|
2.26
|
|
|
119,749
|
|
|
2.98
|
|
|||||
|
Agency-issued collateralized mortgage obligations - fixed rate
|
|
3,855,067
|
|
|
1.94
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
3,855,067
|
|
|
1.94
|
|
|||||
|
Agency-issued collateralized mortgage obligations - variable rate
|
|
1,602,853
|
|
|
0.70
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,602,853
|
|
|
0.70
|
|
|||||
|
Agency-issued commercial mortgage-backed securities
|
|
419,335
|
|
|
1.82
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
419,335
|
|
|
1.82
|
|
|||||
|
Municipal bonds and notes
|
|
90,503
|
|
|
5.98
|
|
|
938
|
|
|
5.32
|
|
|
19,133
|
|
|
5.65
|
|
|
49,986
|
|
|
6.02
|
|
|
20,446
|
|
|
6.25
|
|
|||||
|
Total
|
|
$
|
10,899,537
|
|
|
1.69
|
|
|
$
|
252,351
|
|
|
1.07
|
|
|
$
|
2,603,707
|
|
|
1.51
|
|
|
$
|
2,026,029
|
|
|
2.17
|
|
|
$
|
6,017,450
|
|
|
1.64
|
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Gross gains on investment securities:
|
|
|
|
|
||||
|
Available-for-sale securities, at fair value (1)
|
|
$
|
—
|
|
|
$
|
21
|
|
|
Marketable securities (fair value accounting)
|
|
1,918
|
|
|
316
|
|
||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
||||
|
Venture capital and private equity fund investments
|
|
27,381
|
|
|
26,110
|
|
||
|
Other venture capital investments
|
|
2,640
|
|
|
1,777
|
|
||
|
Other investments
|
|
—
|
|
|
21
|
|
||
|
Non-marketable securities (equity method accounting):
|
|
|
|
|
||||
|
Other investments
|
|
2,715
|
|
|
1,422
|
|
||
|
Non-marketable securities (cost method accounting):
|
|
|
|
|
||||
|
Venture capital and private equity fund investments
|
|
1,023
|
|
|
407
|
|
||
|
Other investments
|
|
145
|
|
|
42
|
|
||
|
Total gross gains on investment securities
|
|
35,822
|
|
|
30,116
|
|
||
|
Gross losses on investment securities:
|
|
|
|
|
||||
|
Available-for-sale securities, at fair value (1)
|
|
(45
|
)
|
|
(895
|
)
|
||
|
Marketable securities (fair value accounting)
|
|
(2,073
|
)
|
|
—
|
|
||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
||||
|
Venture capital and private equity fund investments
|
|
(4,742
|
)
|
|
(13,915
|
)
|
||
|
Other venture capital investments
|
|
(464
|
)
|
|
(6,663
|
)
|
||
|
Non-marketable securities (equity method accounting):
|
|
|
|
|
||||
|
Other investments
|
|
(245
|
)
|
|
(376
|
)
|
||
|
Non-marketable securities (cost method accounting):
|
|
|
|
|
||||
|
Venture capital and private equity fund investments
|
|
(469
|
)
|
|
(363
|
)
|
||
|
Other investments
|
|
(346
|
)
|
|
(65
|
)
|
||
|
Total gross losses on investment securities
|
|
(8,384
|
)
|
|
(22,277
|
)
|
||
|
Gains on investment securities, net
|
|
$
|
27,438
|
|
|
$
|
7,839
|
|
|
Gains attributable to noncontrolling interests, including carried interest
|
|
$
|
22,296
|
|
|
$
|
7,338
|
|
|
|
|
(1)
|
Includes realized gains on sales of available-for-sale securities that are recognized in the income statement. Unrealized gains on available-for-sale securities are recognized in other comprehensive income. The cost basis of available-for-sale securities sold is determined on a specific identification basis.
|
|
6.
|
Loans and Allowance for Loan Losses
|
|
(Dollars in thousands)
|
|
March 31, 2013
|
|
December 31, 2012
|
||||
|
Commercial loans:
|
|
|
|
|
||||
|
Software
|
|
$
|
3,455,602
|
|
|
$
|
3,261,489
|
|
|
Hardware
|
|
1,220,691
|
|
|
1,118,370
|
|
||
|
Venture capital/private equity
|
|
1,322,123
|
|
|
1,732,699
|
|
||
|
Life science
|
|
1,017,859
|
|
|
1,066,199
|
|
||
|
Premium wine
|
|
139,017
|
|
|
143,511
|
|
||
|
Other
|
|
342,129
|
|
|
315,453
|
|
||
|
Total commercial loans
|
|
7,497,421
|
|
|
7,637,721
|
|
||
|
Real estate secured loans:
|
|
|
|
|
||||
|
Premium wine (1)
|
|
464,713
|
|
|
413,513
|
|
||
|
Consumer loans (2)
|
|
724,894
|
|
|
685,300
|
|
||
|
Total real estate secured loans
|
|
1,189,607
|
|
|
1,098,813
|
|
||
|
Construction loans
|
|
58,573
|
|
|
65,742
|
|
||
|
Consumer loans
|
|
99,289
|
|
|
144,657
|
|
||
|
Total loans, net of unearned income (3)
|
|
$
|
8,844,890
|
|
|
$
|
8,946,933
|
|
|
|
|
(1)
|
Included in our premium wine portfolio are gross construction loans of
$133 million
and
$148 million
at
March 31, 2013
and
December 31, 2012
, respectively.
|
|
(2)
|
Consumer loans secured by real estate at
March 31, 2013
and
December 31, 2012
were comprised of the following:
|
|
(Dollars in thousands)
|
|
March 31, 2013
|
|
December 31, 2012
|
||||
|
Loans for personal residence
|
|
$
|
541,115
|
|
|
$
|
503,378
|
|
|
Loans to eligible employees
|
|
112,314
|
|
|
110,584
|
|
||
|
Home equity lines of credit
|
|
71,465
|
|
|
71,338
|
|
||
|
Consumer loans secured by real estate
|
|
$
|
724,894
|
|
|
$
|
685,300
|
|
|
(3)
|
Included within our total loan portfolio are credit card loans of
$77 million
and
$64 million
at
March 31, 2013
and
December 31, 2012
, respectively.
|
|
(Dollars in thousands)
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
Commercial loans:
|
|
|
|
|
||||
|
Software
|
|
$
|
3,455,602
|
|
|
$
|
3,261,489
|
|
|
Hardware
|
|
1,220,691
|
|
|
1,118,370
|
|
||
|
Venture capital/private equity
|
|
1,322,123
|
|
|
1,732,699
|
|
||
|
Life science
|
|
1,017,859
|
|
|
1,066,199
|
|
||
|
Premium wine
|
|
603,730
|
|
|
557,024
|
|
||
|
Other
|
|
400,702
|
|
|
381,195
|
|
||
|
Total commercial loans
|
|
8,020,707
|
|
|
8,116,976
|
|
||
|
Consumer loans:
|
|
|
|
|
||||
|
Real estate secured loans
|
|
724,894
|
|
|
685,300
|
|
||
|
Other consumer loans
|
|
99,289
|
|
|
144,657
|
|
||
|
Total consumer loans
|
|
824,183
|
|
|
829,957
|
|
||
|
Total loans, net of unearned income
|
|
$
|
8,844,890
|
|
|
$
|
8,946,933
|
|
|
(Dollars in thousands)
|
|
30 - 59
Days Past
Due
|
|
60 - 89
Days Past
Due
|
|
Greater
Than 90
Days Past
Due
|
|
Total Past
Due
|
|
Current
|
|
Loans Past Due
90 Days or
More Still
Accruing
Interest
|
||||||||||||
|
March 31, 2013:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Software
|
|
$
|
2,739
|
|
|
$
|
1,493
|
|
|
$
|
5
|
|
|
$
|
4,237
|
|
|
$
|
3,480,632
|
|
|
$
|
5
|
|
|
Hardware
|
|
4,034
|
|
|
19
|
|
|
31
|
|
|
4,084
|
|
|
1,206,431
|
|
|
31
|
|
||||||
|
Venture capital/private equity
|
|
84
|
|
|
1
|
|
|
—
|
|
|
85
|
|
|
1,335,476
|
|
|
—
|
|
||||||
|
Life science
|
|
5,886
|
|
|
220
|
|
|
—
|
|
|
6,106
|
|
|
1,021,715
|
|
|
—
|
|
||||||
|
Premium wine
|
|
1,700
|
|
|
—
|
|
|
—
|
|
|
1,700
|
|
|
600,383
|
|
|
—
|
|
||||||
|
Other
|
|
185
|
|
|
—
|
|
|
—
|
|
|
185
|
|
|
398,877
|
|
|
—
|
|
||||||
|
Total commercial loans
|
|
14,628
|
|
|
1,733
|
|
|
36
|
|
|
16,397
|
|
|
8,043,514
|
|
|
36
|
|
||||||
|
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Real estate secured loans
|
|
605
|
|
|
—
|
|
|
—
|
|
|
605
|
|
|
719,801
|
|
|
—
|
|
||||||
|
Other consumer loans
|
|
385
|
|
|
—
|
|
|
—
|
|
|
385
|
|
|
97,781
|
|
|
—
|
|
||||||
|
Total consumer loans
|
|
990
|
|
|
—
|
|
|
—
|
|
|
990
|
|
|
817,582
|
|
|
—
|
|
||||||
|
Total gross loans excluding impaired loans
|
|
15,618
|
|
|
1,733
|
|
|
36
|
|
|
17,387
|
|
|
8,861,096
|
|
|
36
|
|
||||||
|
Impaired loans
|
|
2,459
|
|
|
1,740
|
|
|
13,929
|
|
|
18,128
|
|
|
26,218
|
|
|
—
|
|
||||||
|
Total gross loans
|
|
$
|
18,077
|
|
|
$
|
3,473
|
|
|
$
|
13,965
|
|
|
$
|
35,515
|
|
|
$
|
8,887,314
|
|
|
$
|
36
|
|
|
December 31, 2012:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Software
|
|
$
|
5,890
|
|
|
$
|
238
|
|
|
$
|
19
|
|
|
$
|
6,147
|
|
|
$
|
3,284,489
|
|
|
$
|
19
|
|
|
Hardware
|
|
167
|
|
|
32
|
|
|
—
|
|
|
199
|
|
|
1,107,422
|
|
|
—
|
|
||||||
|
Venture capital/private equity
|
|
7
|
|
|
—
|
|
|
—
|
|
|
7
|
|
|
1,749,896
|
|
|
—
|
|
||||||
|
Life science
|
|
207
|
|
|
117
|
|
|
—
|
|
|
324
|
|
|
1,076,468
|
|
|
—
|
|
||||||
|
Premium wine
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
554,886
|
|
|
—
|
|
||||||
|
Other
|
|
280
|
|
|
—
|
|
|
—
|
|
|
280
|
|
|
378,619
|
|
|
—
|
|
||||||
|
Total commercial loans
|
|
6,551
|
|
|
387
|
|
|
19
|
|
|
6,957
|
|
|
8,151,780
|
|
|
19
|
|
||||||
|
Consumer loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Real estate secured loans
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
683,254
|
|
|
—
|
|
||||||
|
Other consumer loans
|
|
111
|
|
|
—
|
|
|
—
|
|
|
111
|
|
|
143,867
|
|
|
—
|
|
||||||
|
Total consumer loans
|
|
111
|
|
|
—
|
|
|
—
|
|
|
111
|
|
|
827,121
|
|
|
—
|
|
||||||
|
Total gross loans excluding impaired loans
|
|
6,662
|
|
|
387
|
|
|
19
|
|
|
7,068
|
|
|
8,978,901
|
|
|
19
|
|
||||||
|
Impaired loans
|
|
3,901
|
|
|
9,676
|
|
|
2,269
|
|
|
15,846
|
|
|
22,433
|
|
|
—
|
|
||||||
|
Total gross loans
|
|
$
|
10,563
|
|
|
$
|
10,063
|
|
|
$
|
2,288
|
|
|
$
|
22,914
|
|
|
$
|
9,001,334
|
|
|
$
|
19
|
|
|
(Dollars in thousands)
|
|
Impaired loans for
which there is a
related allowance
for loan losses
|
|
Impaired loans for
which there is no
related allowance
for loan losses
|
|
Total carrying value of impaired loans
|
|
Total unpaid
principal of impaired loans
|
||||||||
|
March 31, 2013:
|
|
|
|
|
|
|
|
|
||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Software
|
|
$
|
6,094
|
|
|
$
|
—
|
|
|
$
|
6,094
|
|
|
$
|
6,196
|
|
|
Hardware
|
|
20,722
|
|
|
1,944
|
|
|
22,666
|
|
|
41,943
|
|
||||
|
Life Science
|
|
454
|
|
|
—
|
|
|
454
|
|
|
454
|
|
||||
|
Premium wine
|
|
—
|
|
|
4,303
|
|
|
4,303
|
|
|
4,731
|
|
||||
|
Other
|
|
—
|
|
|
5,294
|
|
|
5,294
|
|
|
10,008
|
|
||||
|
Total commercial loans
|
|
27,270
|
|
|
11,541
|
|
|
38,811
|
|
|
63,332
|
|
||||
|
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Real estate secured loans
|
|
2,771
|
|
|
1,672
|
|
|
4,443
|
|
|
9,650
|
|
||||
|
Other consumer loans
|
|
1,092
|
|
|
—
|
|
|
1,092
|
|
|
1,310
|
|
||||
|
Total consumer loans
|
|
3,863
|
|
|
1,672
|
|
|
5,535
|
|
|
10,960
|
|
||||
|
Total
|
|
$
|
31,133
|
|
|
$
|
13,213
|
|
|
$
|
44,346
|
|
|
$
|
74,292
|
|
|
December 31, 2012:
|
|
|
|
|
|
|
|
|
||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Software
|
|
$
|
3,191
|
|
|
$
|
72
|
|
|
$
|
3,263
|
|
|
$
|
4,475
|
|
|
Hardware
|
|
21,863
|
|
|
—
|
|
|
21,863
|
|
|
27,876
|
|
||||
|
Life science
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Premium wine
|
|
—
|
|
|
4,398
|
|
|
4,398
|
|
|
4,716
|
|
||||
|
Other
|
|
—
|
|
|
5,415
|
|
|
5,415
|
|
|
9,859
|
|
||||
|
Total commercial loans
|
|
25,054
|
|
|
9,885
|
|
|
34,939
|
|
|
46,926
|
|
||||
|
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Real estate secured loans
|
|
—
|
|
|
2,239
|
|
|
2,239
|
|
|
7,185
|
|
||||
|
Other consumer loans
|
|
1,101
|
|
|
—
|
|
|
1,101
|
|
|
1,300
|
|
||||
|
Total consumer loans
|
|
1,101
|
|
|
2,239
|
|
|
3,340
|
|
|
8,485
|
|
||||
|
Total
|
|
$
|
26,155
|
|
|
$
|
12,124
|
|
|
$
|
38,279
|
|
|
$
|
55,411
|
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Average impaired loans:
|
|
|
|
|
||||
|
Commercial loans:
|
|
|
|
|
||||
|
Software
|
|
$
|
4,114
|
|
|
$
|
1,536
|
|
|
Hardware
|
|
23,632
|
|
|
12,262
|
|
||
|
Life science
|
|
314
|
|
|
146
|
|
||
|
Premium wine
|
|
4,336
|
|
|
3,383
|
|
||
|
Other
|
|
5,218
|
|
|
4,644
|
|
||
|
Total commercial loans
|
|
37,614
|
|
|
21,971
|
|
||
|
Consumer loans:
|
|
|
|
|
||||
|
Real estate secured loans
|
|
2,676
|
|
|
12,847
|
|
||
|
Other consumer loans
|
|
1,129
|
|
|
3,019
|
|
||
|
Total consumer loans
|
|
3,805
|
|
|
15,866
|
|
||
|
Total average impaired loans
|
|
$
|
41,419
|
|
|
$
|
37,837
|
|
|
Three months ended March 31, 2013 (dollars in thousands)
|
|
Beginning Balance December 31, 2012
|
|
Charge-offs
|
|
Recoveries
|
|
Provision for
(Reduction of) Loan Losses
|
|
Ending Balance March 31, 2013
|
||||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Software
|
|
$
|
42,648
|
|
|
$
|
(1,518
|
)
|
|
$
|
242
|
|
|
$
|
3,638
|
|
|
$
|
45,010
|
|
|
Hardware
|
|
29,761
|
|
|
(1,997
|
)
|
|
446
|
|
|
(341
|
)
|
|
27,869
|
|
|||||
|
Venture capital/private equity
|
|
9,963
|
|
|
—
|
|
|
—
|
|
|
519
|
|
|
10,482
|
|
|||||
|
Life science
|
|
13,606
|
|
|
(2,070
|
)
|
|
203
|
|
|
2,207
|
|
|
13,946
|
|
|||||
|
Premium wine
|
|
3,523
|
|
|
—
|
|
|
90
|
|
|
86
|
|
|
3,699
|
|
|||||
|
Other
|
|
3,912
|
|
|
(41
|
)
|
|
6
|
|
|
98
|
|
|
3,975
|
|
|||||
|
Total commercial loans
|
|
103,413
|
|
|
(5,626
|
)
|
|
987
|
|
|
6,207
|
|
|
104,981
|
|
|||||
|
Consumer loans
|
|
7,238
|
|
|
—
|
|
|
380
|
|
|
(394
|
)
|
|
7,224
|
|
|||||
|
Total allowance for loan losses
|
|
$
|
110,651
|
|
|
$
|
(5,626
|
)
|
|
$
|
1,367
|
|
|
$
|
5,813
|
|
|
$
|
112,205
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2012 (dollars in thousands)
|
|
Beginning Balance December 31, 2011
|
|
Charge-offs
|
|
Recoveries
|
|
(Reduction of)Provision for
Loan Losses
|
|
Ending Balance March 31, 2012
|
||||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Software
|
|
$
|
38,263
|
|
|
$
|
(859
|
)
|
|
$
|
2,759
|
|
|
$
|
(4,738
|
)
|
|
$
|
35,425
|
|
|
Hardware
|
|
16,810
|
|
|
(3,848
|
)
|
|
105
|
|
|
17,281
|
|
|
30,348
|
|
|||||
|
Venture capital/private equity
|
|
7,319
|
|
|
—
|
|
|
—
|
|
|
(105
|
)
|
|
7,214
|
|
|||||
|
Life science
|
|
10,243
|
|
|
(113
|
)
|
|
221
|
|
|
(59
|
)
|
|
10,292
|
|
|||||
|
Premium wine
|
|
3,914
|
|
|
—
|
|
|
78
|
|
|
(254
|
)
|
|
3,738
|
|
|||||
|
Other
|
|
5,817
|
|
|
(2,170
|
)
|
|
44
|
|
|
1,111
|
|
|
4,802
|
|
|||||
|
Total commercial loans
|
|
82,366
|
|
|
(6,990
|
)
|
|
3,207
|
|
|
13,236
|
|
|
91,819
|
|
|||||
|
Consumer loans
|
|
7,581
|
|
|
—
|
|
|
229
|
|
|
1,293
|
|
|
9,103
|
|
|||||
|
Total allowance for loan losses
|
|
$
|
89,947
|
|
|
$
|
(6,990
|
)
|
|
$
|
3,436
|
|
|
$
|
14,529
|
|
|
$
|
100,922
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||||
|
(Dollars in thousands)
|
|
Individually Evaluated for
Impairment
|
|
Collectively Evaluated for
Impairment
|
|
Individually
Evaluated for
Impairment
|
|
Collectively
Evaluated for
Impairment
|
||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Software
|
|
$
|
2,087
|
|
|
$
|
42,923
|
|
|
$
|
762
|
|
|
$
|
41,886
|
|
|
Hardware
|
|
5,016
|
|
|
22,853
|
|
|
5,251
|
|
|
24,510
|
|
||||
|
Venture capital/private equity
|
|
—
|
|
|
10,482
|
|
|
—
|
|
|
9,963
|
|
||||
|
Life science
|
|
201
|
|
|
13,745
|
|
|
—
|
|
|
13,606
|
|
||||
|
Premium wine
|
|
—
|
|
|
3,699
|
|
|
—
|
|
|
3,523
|
|
||||
|
Other
|
|
—
|
|
|
3,975
|
|
|
—
|
|
|
3,912
|
|
||||
|
Total commercial loans
|
|
7,304
|
|
|
97,677
|
|
|
6,013
|
|
|
97,400
|
|
||||
|
Consumer loans
|
|
424
|
|
|
6,800
|
|
|
248
|
|
|
6,990
|
|
||||
|
Total allowance for loan losses
|
|
$
|
7,728
|
|
|
$
|
104,477
|
|
|
$
|
6,261
|
|
|
$
|
104,390
|
|
|
(Dollars in thousands)
|
|
Pass
|
|
Performing
(Criticized)
|
|
Impaired
|
|
Total
|
||||||||
|
March 31, 2013:
|
|
|
|
|
|
|
|
|
||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Software
|
|
$
|
3,250,004
|
|
|
$
|
234,865
|
|
|
$
|
6,094
|
|
|
$
|
3,490,963
|
|
|
Hardware
|
|
1,084,742
|
|
|
125,773
|
|
|
22,666
|
|
|
1,233,181
|
|
||||
|
Venture capital/private equity
|
|
1,334,740
|
|
|
821
|
|
|
—
|
|
|
1,335,561
|
|
||||
|
Life science
|
|
916,649
|
|
|
111,172
|
|
|
454
|
|
|
1,028,275
|
|
||||
|
Premium wine
|
|
590,448
|
|
|
11,635
|
|
|
4,303
|
|
|
606,386
|
|
||||
|
Other
|
|
382,874
|
|
|
16,188
|
|
|
5,294
|
|
|
404,356
|
|
||||
|
Total commercial loans
|
|
7,559,457
|
|
|
500,454
|
|
|
38,811
|
|
|
8,098,722
|
|
||||
|
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Real estate secured loans
|
|
700,850
|
|
|
19,556
|
|
|
4,443
|
|
|
724,849
|
|
||||
|
Other consumer loans
|
|
91,988
|
|
|
6,178
|
|
|
1,092
|
|
|
99,258
|
|
||||
|
Total consumer loans
|
|
792,838
|
|
|
25,734
|
|
|
5,535
|
|
|
824,107
|
|
||||
|
Total gross loans
|
|
$
|
8,352,295
|
|
|
$
|
526,188
|
|
|
$
|
44,346
|
|
|
$
|
8,922,829
|
|
|
December 31, 2012:
|
|
|
|
|
|
|
|
|
||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Software
|
|
$
|
3,050,449
|
|
|
$
|
240,187
|
|
|
$
|
3,263
|
|
|
$
|
3,293,899
|
|
|
Hardware
|
|
970,802
|
|
|
136,819
|
|
|
21,863
|
|
|
1,129,484
|
|
||||
|
Venture capital/private equity
|
|
1,748,663
|
|
|
1,240
|
|
|
—
|
|
|
1,749,903
|
|
||||
|
Life science
|
|
956,276
|
|
|
120,516
|
|
|
—
|
|
|
1,076,792
|
|
||||
|
Premium wine
|
|
545,697
|
|
|
9,189
|
|
|
4,398
|
|
|
559,284
|
|
||||
|
Other
|
|
360,291
|
|
|
18,608
|
|
|
5,415
|
|
|
384,314
|
|
||||
|
Total commercial loans
|
|
7,632,178
|
|
|
526,559
|
|
|
34,939
|
|
|
8,193,676
|
|
||||
|
Consumer loans:
|
|
|
|
|
|
|
|
|
||||||||
|
Real estate secured loans
|
|
663,911
|
|
|
19,343
|
|
|
2,239
|
|
|
685,493
|
|
||||
|
Other consumer loans
|
|
132,818
|
|
|
11,160
|
|
|
1,101
|
|
|
145,079
|
|
||||
|
Total consumer loans
|
|
796,729
|
|
|
30,503
|
|
|
3,340
|
|
|
830,572
|
|
||||
|
Total gross loans
|
|
$
|
8,428,907
|
|
|
$
|
557,062
|
|
|
$
|
38,279
|
|
|
$
|
9,024,248
|
|
|
(Dollars in thousands)
|
|
March 31, 2013
|
|
December 31, 2012
|
||||
|
Loans modified in TDRs:
|
|
|
|
|
||||
|
Commercial loans:
|
|
|
|
|
||||
|
Software
|
|
$
|
1,751
|
|
|
$
|
2,021
|
|
|
Hardware
|
|
19,749
|
|
|
20,514
|
|
||
|
Venture capital/ private equity
|
|
821
|
|
|
—
|
|
||
|
Life science
|
|
454
|
|
|
—
|
|
||
|
Premium wine
|
|
2,561
|
|
|
2,593
|
|
||
|
Other
|
|
5,749
|
|
|
5,900
|
|
||
|
Total commercial loans
|
|
31,085
|
|
|
31,028
|
|
||
|
Consumer loans:
|
|
|
|
|
||||
|
Real estate secured loans
|
|
1,753
|
|
|
2,199
|
|
||
|
Other consumer loans
|
|
1,092
|
|
|
1,101
|
|
||
|
Total consumer loans
|
|
2,845
|
|
|
3,300
|
|
||
|
Total
|
|
$
|
33,930
|
|
|
$
|
34,328
|
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Loans modified in TDRs during the period:
|
|
|
|
|
||||
|
Commercial loans:
|
|
|
|
|
||||
|
Software
|
|
$
|
—
|
|
|
$
|
600
|
|
|
Venture capital/ private equity
|
|
821
|
|
|
—
|
|
||
|
Life science
|
|
454
|
|
|
—
|
|
||
|
Premium wine
|
|
—
|
|
|
405
|
|
||
|
Other
|
|
—
|
|
|
2,416
|
|
||
|
Total commercial loans
|
|
1,275
|
|
|
3,421
|
|
||
|
Consumer loans:
|
|
|
|
|
||||
|
Real estate secured loans
|
|
—
|
|
|
249
|
|
||
|
Other consumer loans
|
|
100
|
|
|
36
|
|
||
|
Total consumer loans
|
|
100
|
|
|
285
|
|
||
|
Total loans modified in TDR’s during the period (1)
|
|
$
|
1,375
|
|
|
$
|
3,706
|
|
|
|
|
(1)
|
During the
three
months ended
March 31, 2013
, we had no partial charge-offs of loans classified as TDRs. There were partial charge-offs of
$0.8 million
on loans classified as TDRs during the
three
months ended
March 31, 2012
.
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
TDRs modified within the previous 12 months that defaulted during the period:
|
|
|
|
|
||||
|
Commercial loans:
|
|
|
|
|
||||
|
Software
|
|
$
|
—
|
|
|
$
|
600
|
|
|
Hardware
|
|
125
|
|
|
—
|
|
||
|
Other
|
|
2,750
|
|
|
—
|
|
||
|
Total commercial loans
|
|
2,875
|
|
|
600
|
|
||
|
Consumer loans:
|
|
|
|
|
||||
|
Real estate secured loans
|
|
247
|
|
|
249
|
|
||
|
Other consumer loans
|
|
—
|
|
|
36
|
|
||
|
Total consumer loans
|
|
247
|
|
|
285
|
|
||
|
Total TDRs modified within the previous 12 months that defaulted in the period
|
|
$
|
3,122
|
|
|
$
|
885
|
|
|
7.
|
|
|
|
|
|
|
|
|
Carrying Value
|
||||||||
|
(Dollars in thousands)
|
|
Maturity
|
|
Principal value at March 31, 2013
|
|
March 31,
2013 |
|
December 31,
2012 |
||||||
|
Short-term borrowings:
|
|
|
|
|
|
|
|
|
||||||
|
Federal funds purchased
|
|
—
|
|
—
|
|
|
—
|
|
|
160,000
|
|
|||
|
Other short-term borrowings
|
|
(1)
|
|
7,460
|
|
|
7,460
|
|
|
6,110
|
|
|||
|
Total short-term borrowings
|
|
|
|
|
|
$
|
7,460
|
|
|
$
|
166,110
|
|
||
|
Long-term debt:
|
|
|
|
|
|
|
|
|
||||||
|
5.375% Senior Notes
|
|
September 15, 2020
|
|
$
|
350,000
|
|
|
$
|
348,048
|
|
|
$
|
347,995
|
|
|
6.05% Subordinated Notes (2)
|
|
June 1, 2017
|
|
45,964
|
|
|
53,993
|
|
|
54,571
|
|
|||
|
7.0% Junior Subordinated Debentures
|
|
October 15, 2033
|
|
50,000
|
|
|
55,153
|
|
|
55,196
|
|
|||
|
Total long-term debt
|
|
|
|
|
|
$
|
457,194
|
|
|
$
|
457,762
|
|
||
|
|
|
(1)
|
Represents cash collateral received from our counterparty for our interest rate swap agreement related to our 6.05% Subordinated Notes.
|
|
(2)
|
At
March 31, 2013
and
December 31, 2012
, included in the carrying value of our 6.05% Subordinated Notes were
$8.5 million
and
$9.0 million
, respectively, related to hedge accounting associated with the notes.
|
|
8.
|
Derivative Financial Instruments
|
|
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||||||||||||||||||||
|
(Dollars in thousands)
|
|
Balance Sheet
Location
|
|
Notional or
Contractual
Amount
|
|
Fair Value
|
|
Collateral
(1)
|
|
Net
Exposure
(2)
|
|
Notional or
Contractual
Amount
|
|
Fair Value
|
|
Collateral
(1)
|
|
Net
Exposure
(2)
|
||||||||||||||||
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Interest rate risks:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Interest rate swaps
|
|
Other assets
|
|
$
|
45,964
|
|
|
$
|
8,506
|
|
|
$
|
7,460
|
|
|
$
|
1,046
|
|
|
$
|
45,964
|
|
|
$
|
9,005
|
|
|
$
|
6,110
|
|
|
$
|
2,895
|
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Currency exchange risks:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Foreign exchange forwards
|
|
Other assets
|
|
46,088
|
|
|
1,051
|
|
|
—
|
|
|
1,051
|
|
|
51,010
|
|
|
488
|
|
|
—
|
|
|
488
|
|
||||||||
|
Foreign exchange forwards
|
|
Other liabilities
|
|
90,536
|
|
|
(1,423
|
)
|
|
—
|
|
|
(1,423
|
)
|
|
102,956
|
|
|
(1,728
|
)
|
|
—
|
|
|
(1,728
|
)
|
||||||||
|
Net exposure
|
|
|
|
|
|
(372
|
)
|
|
—
|
|
|
(372
|
)
|
|
|
|
(1,240
|
)
|
|
—
|
|
|
(1,240
|
)
|
||||||||||
|
Other derivative instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Equity warrant assets
|
|
Other assets
|
|
169,303
|
|
|
72,333
|
|
|
—
|
|
|
72,333
|
|
|
164,332
|
|
|
74,272
|
|
|
—
|
|
|
74,272
|
|
||||||||
|
Other derivatives:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
Client foreign exchange forwards
|
|
Other assets
|
|
425,503
|
|
|
12,216
|
|
|
—
|
|
|
12,216
|
|
|
385,470
|
|
|
11,864
|
|
|
—
|
|
|
11,864
|
|
||||||||
|
Client foreign exchange forwards
|
|
Other liabilities
|
|
363,247
|
|
|
(9,605
|
)
|
|
—
|
|
|
(9,605
|
)
|
|
356,026
|
|
|
(9,930
|
)
|
|
—
|
|
|
(9,930
|
)
|
||||||||
|
Client foreign currency options
|
|
Other assets
|
|
91,765
|
|
|
485
|
|
|
—
|
|
|
485
|
|
|
132,237
|
|
|
1,189
|
|
|
—
|
|
|
1,189
|
|
||||||||
|
Client foreign currency options
|
|
Other liabilities
|
|
91,765
|
|
|
(485
|
)
|
|
—
|
|
|
(485
|
)
|
|
132,237
|
|
|
(1,189
|
)
|
|
—
|
|
|
(1,189
|
)
|
||||||||
|
Loan conversion options
|
|
Other assets
|
|
9,789
|
|
|
1,529
|
|
|
—
|
|
|
1,529
|
|
|
9,782
|
|
|
890
|
|
|
—
|
|
|
890
|
|
||||||||
|
Client interest rate derivatives
|
|
Other assets
|
|
153,074
|
|
|
653
|
|
|
—
|
|
|
653
|
|
|
144,950
|
|
|
558
|
|
|
—
|
|
|
558
|
|
||||||||
|
Client interest rate derivatives
|
|
Other liabilities
|
|
153,074
|
|
|
(691
|
)
|
|
—
|
|
|
(691
|
)
|
|
144,950
|
|
|
(590
|
)
|
|
—
|
|
|
(590
|
)
|
||||||||
|
Net exposure
|
|
|
|
|
|
4,102
|
|
|
—
|
|
|
4,102
|
|
|
|
|
2,792
|
|
|
—
|
|
|
2,792
|
|
||||||||||
|
Net
|
|
|
|
|
|
$
|
84,569
|
|
|
$
|
7,460
|
|
|
$
|
77,109
|
|
|
|
|
$
|
84,829
|
|
|
$
|
6,110
|
|
|
$
|
78,719
|
|
||||
|
|
|
(1)
|
Cash collateral received from our counterparty for our interest rate swap agreement is recorded as a component of “short-term borrowings” on our consolidated balance sheets.
|
|
(2)
|
Net exposure for contracts in a gain position reflects the replacement cost in the event of nonperformance by all such counterparties.
The credit ratings of our institutional counterparties as of March 31, 2013 remain at investment grade or higher and there were no material changes in their credit ratings for the quarter ended March 31, 2013
.
|
|
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
Statement of income location
|
|
2013
|
|
2012
|
||||
|
Derivatives designated as hedging instruments:
|
|
|
|
|
|
|
||||
|
Interest rate risks:
|
|
|
|
|
|
|
||||
|
Net cash benefit associated with interest rate swaps
|
|
Interest expense—borrowings
|
|
$
|
634
|
|
|
$
|
2,229
|
|
|
Changes in fair value of interest rate swaps
|
|
Net gains on derivative instruments
|
|
60
|
|
|
389
|
|
||
|
Net gains associated with interest rate risk derivatives
|
|
|
|
$
|
694
|
|
|
$
|
2,618
|
|
|
Derivatives not designated as hedging instruments:
|
|
|
|
|
|
|
||||
|
Currency exchange risks:
|
|
|
|
|
|
|
||||
|
(Losses) gains on revaluations of foreign currency instruments
|
|
Other noninterest income
|
|
$
|
(7,064
|
)
|
|
$
|
1,659
|
|
|
Gains (losses) on internal foreign exchange forward contracts, net
|
|
Net gains on derivative instruments
|
|
6,200
|
|
|
(2,051
|
)
|
||
|
Net losses associated with currency risk
|
|
|
|
$
|
(864
|
)
|
|
$
|
(392
|
)
|
|
Other derivative instruments:
|
|
|
|
|
|
|
||||
|
Gains on equity warrant assets
|
|
Net gains on derivative instruments
|
|
$
|
3,505
|
|
|
$
|
6,935
|
|
|
Gains on client foreign exchange forward contracts, net
|
|
Net gains on derivative instruments
|
|
$
|
797
|
|
|
$
|
1,065
|
|
|
Net gains (losses) on other derivatives (1)
|
|
Net gains on derivative instruments
|
|
$
|
478
|
|
|
$
|
(362
|
)
|
|
|
|
(1)
|
Primarily represents the change in fair value of loan conversion options.
|
|
|
|
|
|
|
|
|
|
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
|
|
|
||||||||||||||
|
(Dollars in thousands)
|
|
Gross Amounts of Recognized Assets
|
|
Gross Amounts offset in the Statement of Financial Position
|
|
Net Amounts of Assets Presented in the Statement of Financial Position
|
|
Financial Instruments
|
|
Cash Collateral Received
|
|
Net Amount
|
||||||||||||
|
March 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivative Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest rate swaps
|
|
$
|
8,506
|
|
|
$
|
—
|
|
|
$
|
8,506
|
|
|
$
|
(1,046
|
)
|
|
$
|
(7,460
|
)
|
|
$
|
—
|
|
|
Foreign exchange forwards
|
|
13,267
|
|
|
—
|
|
|
13,267
|
|
|
(8,364
|
)
|
|
—
|
|
|
4,903
|
|
||||||
|
Foreign currency options
|
|
485
|
|
|
—
|
|
|
485
|
|
|
(485
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Client interest rate derivatives
|
|
653
|
|
|
—
|
|
|
653
|
|
|
(27
|
)
|
|
—
|
|
|
626
|
|
||||||
|
Total derivative assets:
|
|
22,911
|
|
|
—
|
|
|
22,911
|
|
|
(9,922
|
)
|
|
(7,460
|
)
|
|
5,529
|
|
||||||
|
Reverse repurchase, securities borrowing, and similar arrangements
|
|
338,687
|
|
|
—
|
|
|
338,687
|
|
|
(338,687
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Total
|
|
$
|
361,598
|
|
|
$
|
—
|
|
|
$
|
361,598
|
|
|
$
|
(348,609
|
)
|
|
$
|
(7,460
|
)
|
|
$
|
5,529
|
|
|
December 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivative Assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Interest rate swaps
|
|
$
|
9,005
|
|
|
$
|
—
|
|
|
$
|
9,005
|
|
|
$
|
(2,895
|
)
|
|
$
|
(6,110
|
)
|
|
$
|
—
|
|
|
Foreign exchange forwards
|
|
12,352
|
|
|
—
|
|
|
12,352
|
|
|
(7,363
|
)
|
|
—
|
|
|
4,989
|
|
||||||
|
Foreign currency options
|
|
1,189
|
|
|
—
|
|
|
1,189
|
|
|
(218
|
)
|
|
—
|
|
|
971
|
|
||||||
|
Client interest rate derivatives
|
|
558
|
|
|
—
|
|
|
558
|
|
|
(24
|
)
|
|
—
|
|
|
534
|
|
||||||
|
Total derivative assets:
|
|
23,104
|
|
|
—
|
|
|
23,104
|
|
|
(10,500
|
)
|
|
(6,110
|
)
|
|
6,494
|
|
||||||
|
Reverse repurchase, securities borrowing, and similar arrangements
|
|
133,357
|
|
|
—
|
|
|
133,357
|
|
|
(133,357
|
)
|
|
—
|
|
|
—
|
|
||||||
|
Total
|
|
$
|
156,461
|
|
|
$
|
—
|
|
|
$
|
156,461
|
|
|
$
|
(143,857
|
)
|
|
$
|
(6,110
|
)
|
|
$
|
6,494
|
|
|
|
|
|
|
|
|
|
|
Gross Amounts Not Offset in the Statement of Financial Position But Subject to Master Netting Arrangements
|
|
|
||||||||||||||
|
(Dollars in thousands)
|
|
Gross Amounts of Recognized Liabilities
|
|
Gross Amounts offset in the Statement of Financial Position
|
|
Net Amounts of Liabilities Presented in the Statement of Financial Position
|
|
Financial Instruments
|
|
Cash Collateral Pledged
|
|
Net Amount
|
||||||||||||
|
March 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivative Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Foreign exchange forwards
|
|
$
|
11,028
|
|
|
$
|
—
|
|
|
$
|
11,028
|
|
|
$
|
(4,069
|
)
|
|
$
|
—
|
|
|
$
|
6,959
|
|
|
Foreign currency options
|
|
485
|
|
|
—
|
|
|
485
|
|
|
—
|
|
|
—
|
|
|
485
|
|
||||||
|
Client interest rate derivatives
|
|
691
|
|
|
—
|
|
|
691
|
|
|
(664
|
)
|
|
—
|
|
|
27
|
|
||||||
|
Total derivative liabilities:
|
|
12,204
|
|
|
—
|
|
|
12,204
|
|
|
(4,733
|
)
|
|
—
|
|
|
7,471
|
|
||||||
|
Repurchase, securities lending, and similar arrangements
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Total
|
|
$
|
12,204
|
|
|
$
|
—
|
|
|
$
|
12,204
|
|
|
$
|
(4,733
|
)
|
|
$
|
—
|
|
|
$
|
7,471
|
|
|
December 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Derivative Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Foreign exchange forwards
|
|
$
|
11,658
|
|
|
$
|
—
|
|
|
$
|
11,658
|
|
|
$
|
(5,720
|
)
|
|
$
|
—
|
|
|
$
|
5,938
|
|
|
Foreign currency options
|
|
1,189
|
|
|
—
|
|
|
1,189
|
|
|
(971
|
)
|
|
—
|
|
|
218
|
|
||||||
|
Client interest rate derivatives
|
|
590
|
|
|
—
|
|
|
590
|
|
|
(567
|
)
|
|
—
|
|
|
23
|
|
||||||
|
Total derivative assets:
|
|
13,437
|
|
|
—
|
|
|
13,437
|
|
|
(7,258
|
)
|
|
—
|
|
|
6,179
|
|
||||||
|
Repurchase, securities lending, and similar arrangements
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
Total
|
|
$
|
13,437
|
|
|
$
|
—
|
|
|
$
|
13,437
|
|
|
$
|
(7,258
|
)
|
|
$
|
—
|
|
|
$
|
6,179
|
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Unused commitment fees
|
|
$
|
3,476
|
|
|
$
|
3,055
|
|
|
Fund management fees
|
|
2,769
|
|
|
2,828
|
|
||
|
Service-based fee income
|
|
1,804
|
|
|
2,374
|
|
||
|
(Losses) gains on revaluation of foreign currency instruments (1)
|
|
(7,064
|
)
|
|
1,885
|
|
||
|
Currency revaluation (losses) gains (2)
|
|
(55
|
)
|
|
615
|
|
||
|
Other
|
|
2,597
|
|
|
2,321
|
|
||
|
Total other noninterest income
|
|
$
|
3,527
|
|
|
$
|
13,078
|
|
|
|
|
(1)
|
Represents the revaluation of foreign currency denominated financial instruments issued and held by us, primarily loans, deposits and cash.
|
|
(2)
|
Includes the revaluation of foreign currency denominated assets of certain fund investments. Included in these amounts are gains of
$0.2 million
and
$0.6 million
for the
three
months ended
March 31, 2013
and
2012
, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Telephone
|
|
$
|
1,557
|
|
|
$
|
1,784
|
|
|
Client services
|
|
1,935
|
|
|
1,253
|
|
||
|
Data processing services
|
|
1,912
|
|
|
1,405
|
|
||
|
Tax credit fund amortization
|
|
1,317
|
|
|
1,058
|
|
||
|
Postage and supplies
|
|
538
|
|
|
625
|
|
||
|
Dues and publications
|
|
458
|
|
|
474
|
|
||
|
Other
|
|
2,218
|
|
|
1,208
|
|
||
|
Total other noninterest expense
|
|
$
|
9,935
|
|
|
$
|
7,807
|
|
|
10.
|
Segment Reporting
|
|
•
|
Global Commercial Bank
provides solutions to the financial needs of commercial clients through lending, deposit products, cash management services, and global banking and trade products and services. It also serves the needs of our non-U.S. clients with global banking products, including loans, deposits and global finance, in key foreign entrepreneurial markets, where applicable. Our Global Commercial Bank segment is comprised of results from our Commercial Bank, and also includes SVB Specialty Lending, SVB Analytics and our Debt Fund Investments. (For further description of these operating segments, refer to Note 20—“Segment Reporting” under Part II, Item 8 of our
2012
Form 10-K.)
|
|
•
|
SVB Private Bank
provides banking products and a range of credit services primarily to venture capital/private equity professionals using both long-term secured and short-term unsecured lines of credit.
|
|
•
|
SVB Capital
is the venture capital investment arm of SVBFG, which focuses primarily on funds management. SVB Capital manages funds (primarily venture capital funds) on behalf of third party limited partners and SVB Financial Group. The SVB Capital family of funds is comprised of funds of funds and direct venture funds. SVB Capital generates income for the Company primarily through management fees, carried interest arrangements and returns through the Company’s investments in the funds.
|
|
(Dollars in thousands)
|
|
Global
Commercial
Bank (1)
|
|
SVB Private
Bank
|
|
SVB Capital (1)
|
|
Other Items
|
|
Total
|
||||||||||
|
Three months ended March 31, 2013
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net interest income
|
|
$
|
148,936
|
|
|
$
|
6,104
|
|
|
$
|
1
|
|
|
$
|
8,128
|
|
|
$
|
163,169
|
|
|
(Provision for) reduction of loan losses
|
|
(6,207
|
)
|
|
394
|
|
|
—
|
|
|
—
|
|
|
(5,813
|
)
|
|||||
|
Noninterest income
|
|
46,541
|
|
|
234
|
|
|
5,441
|
|
|
26,388
|
|
|
78,604
|
|
|||||
|
Noninterest expense (2)
|
|
(105,578
|
)
|
|
(3,461
|
)
|
|
(2,386
|
)
|
|
(37,589
|
)
|
|
(149,014
|
)
|
|||||
|
Income (loss) before income tax expense (3)
|
|
$
|
83,692
|
|
|
$
|
3,271
|
|
|
$
|
3,056
|
|
|
$
|
(3,073
|
)
|
|
$
|
86,946
|
|
|
Total average loans, net of unearned income
|
|
$
|
7,868,587
|
|
|
$
|
844,807
|
|
|
$
|
—
|
|
|
$
|
(32,477
|
)
|
|
$
|
8,680,917
|
|
|
Total average assets (4)
|
|
20,463,477
|
|
|
853,932
|
|
|
238,743
|
|
|
758,407
|
|
|
22,314,559
|
|
|||||
|
Total average deposits
|
|
18,302,877
|
|
|
470,673
|
|
|
—
|
|
|
11,963
|
|
|
18,785,513
|
|
|||||
|
Three months ended March 31, 2012
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Net interest income
|
|
$
|
143,264
|
|
|
$
|
4,965
|
|
|
$
|
7
|
|
|
$
|
2,701
|
|
|
$
|
150,937
|
|
|
Provision for loan losses
|
|
(13,236
|
)
|
|
(1,293
|
)
|
|
—
|
|
|
—
|
|
|
(14,529
|
)
|
|||||
|
Noninterest income
|
|
39,928
|
|
|
157
|
|
|
3,587
|
|
|
15,621
|
|
|
59,293
|
|
|||||
|
Noninterest expense (2)
|
|
(96,443
|
)
|
|
(3,126
|
)
|
|
(2,536
|
)
|
|
(29,907
|
)
|
|
(132,012
|
)
|
|||||
|
Income before income tax expense (3)
|
|
$
|
73,513
|
|
|
$
|
703
|
|
|
$
|
1,058
|
|
|
$
|
(11,585
|
)
|
|
$
|
63,689
|
|
|
Total average loans, net of unearned income
|
|
$
|
6,031,356
|
|
|
$
|
737,968
|
|
|
$
|
—
|
|
|
$
|
35,024
|
|
|
$
|
6,804,348
|
|
|
Total average assets (4)
|
|
18,556,741
|
|
|
741,962
|
|
|
260,127
|
|
|
673,713
|
|
|
20,232,543
|
|
|||||
|
Total average deposits
|
|
16,702,114
|
|
|
240,500
|
|
|
—
|
|
|
23,149
|
|
|
16,965,763
|
|
|||||
|
|
|
(1)
|
Global Commercial Bank’s and SVB Capital’s components of net interest income, noninterest income, noninterest expense and total average assets are shown net of noncontrolling interests for all periods presented.
|
|
(2)
|
The Global Commercial Bank segment includes direct depreciation and amortization of
$5.0 million
and
$3.4 million
for the
three
months ended
March 31, 2013
and
2012
, respectively.
|
|
(3)
|
The internal reporting model used by management to assess segment performance does not calculate income tax expense by segment. Our effective tax rate is a reasonable approximation of the segment rates.
|
|
(4)
|
Total average assets equals the greater of total average assets or the sum of total liabilities and total stockholders’ equity for each segment.
|
|
11.
|
Off-Balance Sheet Arrangements, Guarantees and Other Commitments
|
|
(Dollars in thousands)
|
|
March 31,
2013 |
|
December 31,
2012 |
||||
|
Loan commitments available for funding: (1)
|
|
|
|
|
||||
|
Fixed interest rate commitments
|
|
$
|
830,278
|
|
|
$
|
862,120
|
|
|
Variable interest rate commitments
|
|
7,504,108
|
|
|
6,906,580
|
|
||
|
Total loan commitments available for funding
|
|
8,334,386
|
|
|
7,768,700
|
|
||
|
Commercial and standby letters of credit (2)
|
|
835,951
|
|
|
842,091
|
|
||
|
Total unfunded credit commitments
|
|
$
|
9,170,337
|
|
|
$
|
8,610,791
|
|
|
Commitments unavailable for funding (3)
|
|
$
|
1,371,135
|
|
|
$
|
1,315,072
|
|
|
Maximum lending limits for accounts receivable factoring arrangements (4)
|
|
897,344
|
|
|
880,057
|
|
||
|
Reserve for unfunded credit commitments (5)
|
|
24,300
|
|
|
22,299
|
|
||
|
|
|
(1)
|
Represents commitments which are available for funding, due to clients meeting all collateral, compliance and financial covenants required under loan commitment agreements.
|
|
(2)
|
See below for additional information on our commercial and standby letters of credit.
|
|
(3)
|
Represents commitments which are currently unavailable for funding, due to clients failing to meet all collateral, compliance and financial covenants under loan commitment agreements.
|
|
(4)
|
We extend credit under accounts receivable factoring arrangements when our clients’ sales invoices are deemed creditworthy under existing underwriting practices.
|
|
(5)
|
Our reserve for unfunded credit commitments includes an allowance for both our unfunded loan commitments and our letters of credit.
|
|
(Dollars in thousands)
|
|
Expires In One
Year or Less
|
|
Expires After
One Year
|
|
Total Amount
Outstanding
|
|
Maximum Amount
of Future Payments
|
||||||||
|
Financial standby letters of credit
|
|
$
|
713,950
|
|
|
$
|
55,950
|
|
|
$
|
769,900
|
|
|
$
|
769,900
|
|
|
Performance standby letters of credit
|
|
48,651
|
|
|
9,600
|
|
|
58,251
|
|
|
58,251
|
|
||||
|
Commercial letters of credit
|
|
7,800
|
|
|
—
|
|
|
7,800
|
|
|
7,800
|
|
||||
|
Total
|
|
$
|
770,401
|
|
|
$
|
65,550
|
|
|
$
|
835,951
|
|
|
$
|
835,951
|
|
|
Our Ownership in Limited Partnership
(Dollars in thousands)
|
|
SVBFG Capital Commitments
|
|
SVBFG Unfunded
Commitments
|
|
SVBFG Ownership
of each Fund
|
|||||
|
Silicon Valley BancVentures, LP
|
|
$
|
6,000
|
|
|
$
|
270
|
|
|
10.7
|
%
|
|
SVB Capital Partners II, LP (1)
|
|
1,200
|
|
|
162
|
|
|
5.1
|
|
||
|
SVB Capital Shanghai Yangpu Venture Capital Fund
|
|
934
|
|
|
161
|
|
|
6.8
|
|
||
|
SVB Strategic Investors Fund, LP
|
|
15,300
|
|
|
688
|
|
|
12.6
|
|
||
|
SVB Strategic Investors Fund II, LP
|
|
15,000
|
|
|
1,050
|
|
|
8.6
|
|
||
|
SVB Strategic Investors Fund III, LP
|
|
15,000
|
|
|
2,063
|
|
|
5.9
|
|
||
|
SVB Strategic Investors Fund IV, LP
|
|
12,239
|
|
|
3,427
|
|
|
5.0
|
|
||
|
Strategic Investors Fund V Funds
|
|
1,000
|
|
|
833
|
|
|
Various
|
|
||
|
Strategic Investors Fund VI Funds
|
|
500
|
|
|
500
|
|
|
Various
|
|
||
|
SVB Capital Preferred Return Fund, LP
|
|
12,688
|
|
|
—
|
|
|
20.0
|
|
||
|
SVB Capital—NT Growth Partners, LP
|
|
24,670
|
|
|
1,340
|
|
|
33.0
|
|
||
|
Other private equity fund (2)
|
|
9,338
|
|
|
—
|
|
|
58.2
|
|
||
|
Partners for Growth, LP
|
|
25,000
|
|
|
9,750
|
|
|
50.0
|
|
||
|
Partners for Growth II, LP
|
|
15,000
|
|
|
4,950
|
|
|
24.2
|
|
||
|
Gold Hill Venture Lending 03, LP (3)
|
|
20,000
|
|
|
—
|
|
|
9.3
|
|
||
|
Other fund investments (4)
|
|
335,609
|
|
|
65,132
|
|
|
Various
|
|
||
|
Total
|
|
$
|
509,478
|
|
|
$
|
90,326
|
|
|
|
|
|
|
|
(1)
|
Our ownership includes direct ownership of
1.3 percent
and indirect ownership interest of
3.8 percent
through our investment in SVB Strategic Investors Fund II, LP.
|
|
(2)
|
Our ownership includes direct ownership of
41.5 percent
and indirect ownership interests of
12.6 percent
and
4.1 percent
in the fund through our ownership interest of SVB Capital - NT Growth Partners, LP and SVB Capital Preferred Return Fund, LP, respectively.
|
|
(3)
|
Our ownership includes direct ownership of
4.8 percent
and indirect ownership interest of
4.5 percent
through GHLLC.
|
|
(4)
|
Represents commitments to
317
funds (primarily venture capital funds) where our ownership interest is generally less than
5 percent
of the voting interests of each such fund.
|
|
Limited Partnership
(Dollars in thousands)
|
Unfunded
Commitments
|
||
|
SVB Strategic Investors Fund, LP
|
$
|
2,298
|
|
|
SVB Strategic Investors Fund II, LP
|
8,475
|
|
|
|
SVB Strategic Investors Fund III, LP
|
33,462
|
|
|
|
SVB Strategic Investors Fund IV, LP
|
83,897
|
|
|
|
Strategic Investors Fund V Funds
|
282,046
|
|
|
|
Strategic Investors Fund VI Funds
|
3,500
|
|
|
|
SVB Capital Preferred Return Fund, LP
|
14,286
|
|
|
|
SVB Capital—NT Growth Partners, LP
|
16,289
|
|
|
|
Other private equity fund
|
4,229
|
|
|
|
Total
|
$
|
448,482
|
|
|
12.
|
Income Taxes
|
|
13.
|
Fair Value of Financial Instruments
|
|
(Dollars in thousands)
|
|
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
|
|
Significant Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Balance at March 31, 2013
|
||||||||
|
Assets
|
|
|
|
|
|
|
|
|
||||||||
|
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
||||||||
|
U.S. treasury securities
|
|
$
|
—
|
|
|
$
|
100,046
|
|
|
$
|
—
|
|
|
$
|
100,046
|
|
|
U.S. agency debentures
|
|
—
|
|
|
3,483,903
|
|
|
—
|
|
|
3,483,903
|
|
||||
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
|
Agency-issued mortgage-backed securities
|
|
—
|
|
|
1,347,830
|
|
|
—
|
|
|
1,347,830
|
|
||||
|
Agency-issued collateralized mortgage obligations - fixed rate
|
|
—
|
|
|
3,855,067
|
|
|
—
|
|
|
3,855,067
|
|
||||
|
Agency-issued collateralized mortgage obligations - variable rate
|
|
—
|
|
|
1,602,853
|
|
|
—
|
|
|
1,602,853
|
|
||||
|
Agency-issued commercial mortgage-backed securities
|
|
—
|
|
|
419,335
|
|
|
—
|
|
|
419,335
|
|
||||
|
Municipal bonds and notes
|
|
—
|
|
|
90,503
|
|
|
—
|
|
|
90,503
|
|
||||
|
Equity securities
|
|
5,879
|
|
|
2,747
|
|
|
—
|
|
|
8,626
|
|
||||
|
Total available-for-sale securities
|
|
5,879
|
|
|
10,902,284
|
|
|
—
|
|
|
10,908,163
|
|
||||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
|
|
||||||||
|
Venture capital and private equity fund investments
|
|
—
|
|
|
—
|
|
|
701,076
|
|
|
701,076
|
|
||||
|
Other venture capital investments
|
|
—
|
|
|
—
|
|
|
124,786
|
|
|
124,786
|
|
||||
|
Total non-marketable securities (fair value accounting)
|
|
—
|
|
|
—
|
|
|
825,862
|
|
|
825,862
|
|
||||
|
Other assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Marketable securities
|
|
913
|
|
|
9,265
|
|
|
—
|
|
|
10,178
|
|
||||
|
Interest rate swaps
|
|
—
|
|
|
8,506
|
|
|
—
|
|
|
8,506
|
|
||||
|
Foreign exchange forward and option contracts
|
|
—
|
|
|
13,752
|
|
|
—
|
|
|
13,752
|
|
||||
|
Equity warrant assets
|
|
—
|
|
|
6,287
|
|
|
66,046
|
|
|
72,333
|
|
||||
|
Loan conversion options
|
|
—
|
|
|
1,529
|
|
|
—
|
|
|
1,529
|
|
||||
|
Client interest rate derivatives
|
|
—
|
|
|
653
|
|
|
—
|
|
|
653
|
|
||||
|
Total assets (1)
|
|
$
|
6,792
|
|
|
$
|
10,942,276
|
|
|
$
|
891,908
|
|
|
$
|
11,840,976
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign exchange forward and option contracts
|
|
$
|
—
|
|
|
$
|
11,513
|
|
|
$
|
—
|
|
|
$
|
11,513
|
|
|
Client interest rate derivatives
|
|
—
|
|
|
691
|
|
|
—
|
|
|
691
|
|
||||
|
Total liabilities
|
|
$
|
—
|
|
|
$
|
12,204
|
|
|
$
|
—
|
|
|
$
|
12,204
|
|
|
|
|
(1)
|
Included in Level 1, Level 2, and Level 3 assets are
$0.8 million
,
$8.8 million
, and
$740 million
, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
|
|
(Dollars in thousands)
|
|
Quoted Prices in
Active Markets
for Identical
Assets
(Level 1)
|
|
Significant Other
Observable
Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Balance at December 31, 2012
|
||||||||
|
Assets
|
|
|
|
|
|
|
|
|
||||||||
|
Available-for-sale securities:
|
|
|
|
|
|
|
|
|
||||||||
|
U.S. treasury securities
|
|
$
|
—
|
|
|
$
|
25,247
|
|
|
$
|
—
|
|
|
$
|
25,247
|
|
|
U.S. agency debentures
|
|
—
|
|
|
3,447,628
|
|
|
—
|
|
|
3,447,628
|
|
||||
|
Residential mortgage-backed securities:
|
|
|
|
|
|
|
|
|
||||||||
|
Agency-issued mortgage-backed securities
|
|
—
|
|
|
1,473,433
|
|
|
—
|
|
|
1,473,433
|
|
||||
|
Agency-issued collateralized mortgage obligations - fixed rate
|
|
—
|
|
|
4,103,974
|
|
|
—
|
|
|
4,103,974
|
|
||||
|
Agency-issued collateralized mortgage obligations - variable rate
|
|
—
|
|
|
1,772,748
|
|
|
—
|
|
|
1,772,748
|
|
||||
|
Agency-issued commercial mortgage-backed securities
|
|
—
|
|
|
422,098
|
|
|
—
|
|
|
422,098
|
|
||||
|
Municipal bonds and notes
|
|
—
|
|
|
93,529
|
|
|
—
|
|
|
93,529
|
|
||||
|
Equity securities
|
|
4,520
|
|
|
—
|
|
|
—
|
|
|
4,520
|
|
||||
|
Total available-for-sale securities
|
|
4,520
|
|
|
11,338,657
|
|
|
—
|
|
|
11,343,177
|
|
||||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
|
|
||||||||
|
Venture capital and private equity fund investments
|
|
—
|
|
|
—
|
|
|
665,921
|
|
|
665,921
|
|
||||
|
Other venture capital investments
|
|
—
|
|
|
—
|
|
|
127,091
|
|
|
127,091
|
|
||||
|
Total non-marketable securities (fair value accounting)
|
|
—
|
|
|
—
|
|
|
793,012
|
|
|
793,012
|
|
||||
|
Other assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Marketable securities
|
|
1,144
|
|
|
9,184
|
|
|
—
|
|
|
10,328
|
|
||||
|
Interest rate swaps
|
|
—
|
|
|
9,005
|
|
|
—
|
|
|
9,005
|
|
||||
|
Foreign exchange forward and option contracts
|
|
—
|
|
|
13,541
|
|
|
—
|
|
|
13,541
|
|
||||
|
Equity warrant assets
|
|
—
|
|
|
8,143
|
|
|
66,129
|
|
|
74,272
|
|
||||
|
Loan conversion options
|
|
—
|
|
|
890
|
|
|
—
|
|
|
890
|
|
||||
|
Client interest rate derivatives
|
|
—
|
|
|
558
|
|
|
—
|
|
|
558
|
|
||||
|
Total assets (1)
|
|
$
|
5,664
|
|
|
$
|
11,379,978
|
|
|
$
|
859,141
|
|
|
$
|
12,244,783
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
||||||||
|
Foreign exchange forward and option contracts
|
|
$
|
—
|
|
|
$
|
12,847
|
|
|
$
|
—
|
|
|
$
|
12,847
|
|
|
Client interest rate derivatives
|
|
—
|
|
|
590
|
|
|
—
|
|
|
590
|
|
||||
|
Total liabilities
|
|
$
|
—
|
|
|
$
|
13,437
|
|
|
$
|
—
|
|
|
$
|
13,437
|
|
|
|
|
(1)
|
Included in Level 1, Level 2, and Level 3 assets are
$1.1 million
,
$8.7 million
, and
$708 million
, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
|
|
(Dollars in thousands)
|
|
Beginning
Balance
|
|
Total Realized and Unrealized Gains (Losses) Included in Income
|
|
Purchases
|
|
Sales
|
|
Issuances
|
|
Distributions and Other Settlements
|
|
Transfers Into Level 3
|
|
Transfers Out of Level 3
|
|
Ending
Balance
|
||||||||||||||||||
|
Three months ended March 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Venture capital and private equity fund investments
|
|
$
|
665,921
|
|
|
$
|
22,510
|
|
|
$
|
29,744
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(17,099
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
701,076
|
|
|
Other venture capital investments
|
|
127,091
|
|
|
2,188
|
|
|
166
|
|
|
(21
|
)
|
|
—
|
|
|
(1,077
|
)
|
|
—
|
|
|
(3,561
|
)
|
|
124,786
|
|
|||||||||
|
Total non-marketable securities (fair value accounting) (1)
|
|
793,012
|
|
|
24,698
|
|
|
29,910
|
|
|
(21
|
)
|
|
—
|
|
|
(18,176
|
)
|
|
—
|
|
|
(3,561
|
)
|
|
825,862
|
|
|||||||||
|
Other assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Equity warrant assets (2)
|
|
66,129
|
|
|
1,459
|
|
|
—
|
|
|
(2,250
|
)
|
|
1,926
|
|
|
364
|
|
|
—
|
|
|
(1,582
|
)
|
|
66,046
|
|
|||||||||
|
Total assets
|
|
$
|
859,141
|
|
|
$
|
26,157
|
|
|
$
|
29,910
|
|
|
$
|
(2,271
|
)
|
|
$
|
1,926
|
|
|
$
|
(17,812
|
)
|
|
$
|
—
|
|
|
$
|
(5,143
|
)
|
|
$
|
891,908
|
|
|
Three months ended March 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Venture capital and private equity fund investments
|
|
$
|
611,824
|
|
|
$
|
12,104
|
|
|
$
|
21,716
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(25,288
|
)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
620,356
|
|
|
Other venture capital investments
|
|
124,121
|
|
|
(3,587
|
)
|
|
7,724
|
|
|
(307
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
127,951
|
|
|||||||||
|
Other investments
|
|
987
|
|
|
21
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
|
1,002
|
|
|||||||||
|
Total non-marketable securities (fair value accounting) (1)
|
|
736,932
|
|
|
8,538
|
|
|
29,440
|
|
|
(307
|
)
|
|
—
|
|
|
(25,294
|
)
|
|
—
|
|
|
—
|
|
|
749,309
|
|
|||||||||
|
Other assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||
|
Equity warrant assets (2)
|
|
63,030
|
|
|
3,795
|
|
|
—
|
|
|
(3,643
|
)
|
|
2,300
|
|
|
1
|
|
|
—
|
|
|
(266
|
)
|
|
65,217
|
|
|||||||||
|
Total assets
|
|
$
|
799,962
|
|
|
$
|
12,333
|
|
|
$
|
29,440
|
|
|
$
|
(3,950
|
)
|
|
$
|
2,300
|
|
|
$
|
(25,293
|
)
|
|
$
|
—
|
|
|
$
|
(266
|
)
|
|
$
|
814,526
|
|
|
|
|
(1)
|
Realized and unrealized gains (losses) are recorded on the line items “gains on investment securities, net”, and “other noninterest income”, components of noninterest income.
|
|
(2)
|
Realized and unrealized gains (losses) are recorded on the line item “gains on derivative instruments, net”, a component of noninterest income.
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
||||
|
Venture capital and private equity fund investments
|
|
$
|
22,621
|
|
|
$
|
11,649
|
|
|
Other venture capital investments
|
|
526
|
|
|
(2,610
|
)
|
||
|
Other investments
|
|
—
|
|
|
21
|
|
||
|
Total non-marketable securities (fair value accounting) (1)
|
|
23,147
|
|
|
9,060
|
|
||
|
Other assets:
|
|
|
|
|
||||
|
Equity warrant assets (2)
|
|
1,181
|
|
|
1,674
|
|
||
|
Total unrealized gains
|
|
$
|
24,328
|
|
|
$
|
10,734
|
|
|
Unrealized gains attributable to noncontrolling interests
|
|
$
|
21,187
|
|
|
$
|
7,242
|
|
|
|
|
(1)
|
Unrealized gains (losses) are recorded on the line items “gains on investment securities, net”, and “other noninterest income”, components of noninterest income.
|
|
(2)
|
Unrealized gains (losses) are recorded on the line item “gains on derivative instruments, net”, a component of noninterest income.
|
|
(Dollars in thousands)
|
|
Fair value
|
|
Valuation Technique
|
|
Significant Unobservable Inputs
|
|
Weighted
Average
|
|||
|
March 31, 2013:
|
|
|
|
|
|
|
|
|
|||
|
Other venture capital investments (fair value accounting)
|
|
$
|
124,786
|
|
|
Private company equity pricing
|
|
(1)
|
|
(1
|
)
|
|
Equity warrant assets (private portfolio)
|
|
66,046
|
|
|
Modifed Black-Scholes option pricing model
|
|
Volatility
|
|
42.0
|
%
|
|
|
|
|
|
|
|
Risk-Free interest rate
|
|
0.4
|
%
|
|||
|
|
|
|
|
|
Marketability discount (2)
|
|
22.5
|
%
|
|||
|
|
|
|
|
|
Remaining life assumption (3)
|
|
45.0
|
%
|
|||
|
December 31, 2012:
|
|
|
|
|
|
|
|
|
|||
|
Other venture capital investments (fair value accounting)
|
|
127,091
|
|
|
Private company equity pricing
|
|
(1)
|
|
(1
|
)
|
|
|
Equity warrant assets (private portfolio)
|
|
66,129
|
|
|
Modifed Black-Scholes option pricing model
|
|
Volatility
|
|
45.2
|
%
|
|
|
|
|
|
|
|
Risk-Free interest rate
|
|
0.4
|
%
|
|||
|
|
|
|
|
|
Marketability discount (2)
|
|
22.5
|
%
|
|||
|
|
|
|
|
|
Remaining life assumption (3)
|
|
45.0
|
%
|
|||
|
|
|
(1)
|
In determining the fair value of our other venture capital investment portfolio, we evaluate a variety of factors related to each underlying private portfolio company including, but not limited to, actual and forecasted results, cash position, recent or planned transactions and market comparable companies. Additionally, we have ongoing communication with the portfolio companies and venture capital fund managers, to determine whether there is a material change in fair value. These factors are specific to each portfolio company and a weighted average or range of values of the unobservable inputs is not meaningful.
|
|
(2)
|
Our marketability discount is applied to all private company warrants to account for a general lack of liquidity due to the private nature of the associated underlying company. The quantitative measure used is based on long-run averages and is influenced over time by various factors, including market conditions. On a quarterly basis, a sensitivity analysis is performed on our marketability discount.
|
|
(3)
|
We adjust the contractual remaining term of private company warrants based on our best estimate of the actual remaining life, which we determine by utilizing historical data on cancellations and exercises. At
March 31, 2013
, the weighted average
|
|
|
|
|
|
Estimated Fair Value
|
||||||||||||
|
(Dollars in thousands)
|
|
Carrying Amount
|
|
Quoted Prices in Active Markets for Identical Assets
(Level 1)
|
|
Significant Other Observable Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
||||||||
|
March 31, 2013:
|
|
|
|
|
|
|
|
|
||||||||
|
Financial assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Cash and cash equivalents
|
|
$
|
1,519,249
|
|
|
$
|
1,519,249
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Non-marketable securities (cost and equity method accounting)
|
|
389,926
|
|
|
—
|
|
|
—
|
|
|
431,115
|
|
||||
|
Net commercial loans
|
|
7,915,726
|
|
|
—
|
|
|
—
|
|
|
8,086,157
|
|
||||
|
Net consumer loans
|
|
816,959
|
|
|
—
|
|
|
—
|
|
|
853,520
|
|
||||
|
FHLB and FRB stock
|
|
39,806
|
|
|
—
|
|
|
—
|
|
|
39,806
|
|
||||
|
Accrued interest receivable
|
|
64,375
|
|
|
—
|
|
|
64,375
|
|
|
—
|
|
||||
|
Financial liabilities:
|
|
|
|
|
|
|
|
|
||||||||
|
Other short-term borrowings
|
|
7,460
|
|
|
7,460
|
|
|
—
|
|
|
—
|
|
||||
|
Non-maturity deposits (1)
|
|
19,137,749
|
|
|
19,137,749
|
|
|
—
|
|
|
—
|
|
||||
|
Time deposits
|
|
172,159
|
|
|
—
|
|
|
172,054
|
|
|
—
|
|
||||
|
5.375% Senior Notes
|
|
348,048
|
|
|
—
|
|
|
390,831
|
|
|
—
|
|
||||
|
6.05% Subordinated Notes (2)
|
|
53,993
|
|
|
—
|
|
|
58,390
|
|
|
—
|
|
||||
|
7.0% Junior Subordinated Debentures
|
|
55,153
|
|
|
—
|
|
|
53,608
|
|
|
—
|
|
||||
|
Accrued interest payable
|
|
1,967
|
|
|
—
|
|
|
1,967
|
|
|
—
|
|
||||
|
Off-balance sheet financial assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Commitments to extend credit
|
|
—
|
|
|
—
|
|
|
—
|
|
|
21,109
|
|
||||
|
December 31, 2012:
|
|
|
|
|
|
|
|
|
||||||||
|
Financial assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Cash and cash equivalents
|
|
$
|
1,008,983
|
|
|
$
|
1,008,983
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
Non-marketable securities (cost and equity method accounting)
|
|
391,253
|
|
|
—
|
|
|
—
|
|
|
425,741
|
|
||||
|
Net commercial loans
|
|
8,013,563
|
|
|
—
|
|
|
—
|
|
|
8,180,597
|
|
||||
|
Net consumer loans
|
|
822,719
|
|
|
—
|
|
|
—
|
|
|
860,772
|
|
||||
|
FHLB and FRB stock
|
|
39,806
|
|
|
—
|
|
|
—
|
|
|
39,806
|
|
||||
|
Accrued interest receivable
|
|
64,167
|
|
|
—
|
|
|
64,167
|
|
|
—
|
|
||||
|
Financial liabilities:
|
|
|
|
|
|
|
|
|
||||||||
|
Federal funds purchased
|
|
160,000
|
|
|
160,000
|
|
|
—
|
|
|
—
|
|
||||
|
Other short-term borrowings
|
|
6,110
|
|
|
6,110
|
|
|
—
|
|
|
—
|
|
||||
|
Non-maturity deposits (1)
|
|
19,021,264
|
|
|
19,021,264
|
|
|
—
|
|
|
—
|
|
||||
|
Time deposits
|
|
155,188
|
|
|
—
|
|
|
155,027
|
|
|
—
|
|
||||
|
5.375% Senior Notes
|
|
347,995
|
|
|
—
|
|
|
393,701
|
|
|
—
|
|
||||
|
6.05% Subordinated Notes (2)
|
|
54,571
|
|
|
—
|
|
|
61,639
|
|
|
—
|
|
||||
|
7.0% Junior Subordinated Debentures
|
|
55,196
|
|
|
—
|
|
|
51,959
|
|
|
—
|
|
||||
|
Accrued interest payable
|
|
6,494
|
|
|
—
|
|
|
6,494
|
|
|
—
|
|
||||
|
Off-balance sheet financial assets:
|
|
|
|
|
|
|
|
|
||||||||
|
Commitments to extend credit
|
|
—
|
|
|
—
|
|
|
—
|
|
|
20,562
|
|
||||
|
|
|
(1)
|
Includes noninterest-bearing demand deposits, interest-bearing checking accounts, money market accounts and interest-bearing sweep deposits.
|
|
(2)
|
At
March 31, 2013
and
December 31, 2012
, included in the carrying value and estimated fair value of our
6.05%
Subordinated Notes was
$8.5 million
and
$9.0 million
, respectively, related to hedge accounting associated with the notes.
|
|
(Dollars in thousands)
|
|
Carrying Amount
|
|
Fair Value
|
|
Unfunded
Commitments
|
||||||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
||||||
|
Venture capital and private equity fund investments (1)
|
|
$
|
701,076
|
|
|
$
|
701,076
|
|
|
$
|
448,482
|
|
|
Non-marketable securities (equity method accounting):
|
|
|
|
|
|
|
||||||
|
Other investments (2)
|
|
52,180
|
|
|
53,679
|
|
|
17,258
|
|
|||
|
Non-marketable securities (cost method accounting):
|
|
|
|
|
|
|
||||||
|
Venture capital and private equity fund investments (3)
|
|
160,870
|
|
|
199,504
|
|
|
51,007
|
|
|||
|
Total
|
|
$
|
914,126
|
|
|
$
|
954,259
|
|
|
$
|
516,747
|
|
|
|
|
(1)
|
Venture capital and private equity fund investments within non-marketable securities (fair value accounting) include investments made by our managed funds of funds and one of our direct venture funds. These investments represent investments in venture capital and private equity funds that invest primarily in U.S. and global technology and life sciences companies. Included in the fair value and unfunded commitments of fund investments under fair value accounting are
$624 million
and
$440 million
, respectively, attributable to noncontrolling interests. It is estimated that we will receive distributions from the fund investments over the next
10
to
13
years, depending on the age of the funds and any potential extensions of terms of the funds.
|
|
(2)
|
Other investments within non-marketable securities (equity method accounting) include investments in debt funds and venture capital and private equity fund investments that invest in or lend money to primarily U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next
10
to
13
years, depending on the age of the funds.
|
|
(3)
|
Venture capital and private equity fund investments within non-marketable securities (cost method accounting) include investments in venture capital and private equity fund investments that invest primarily in U.S. and global technology and life sciences companies. It is estimated that we will receive distributions from the fund investments over the next
10
to
13
years, depending on the age of the funds and any potential extensions of the terms of the funds.
|
|
14.
|
Legal Matters
|
|
15.
|
Related Parties
|
|
16.
|
Subsequent Events
|
|
•
|
Projections of our net interest income, noninterest income, earnings per share, noninterest expenses (including professional services, compliance, compensation and other costs), cash flows, balance sheet positions, capital expenditures, liquidity and capitalization or other financial items
|
|
•
|
Descriptions of our strategic initiatives, plans or objectives for future operations, including pending sales or acquisitions
|
|
•
|
Forecasts of venture capital/private equity funding and investment levels
|
|
•
|
Forecasts of future interest rates, economic performance, and income from investments
|
|
•
|
Forecasts of expected levels of provisions for loan losses, loan growth and client funds
|
|
•
|
Descriptions of assumptions underlying or relating to any of the foregoing
|
|
▪
|
Market and economic conditions (including interest rate environment, and levels of public offerings, mergers/acquisitions and venture capital financing activities) and the associated impact on us
|
|
▪
|
The sufficiency of our capital, including sources of capital (such as funds generated through retained earnings) and the extent to which capital may be used or required
|
|
▪
|
The adequacy of our liquidity position, including sources of liquidity (such as funds generated through retained earnings)
|
|
▪
|
The adequacy of our liquidity position, including sources of liquidity (such as funds generated through retained earnings)
|
|
▪
|
The realization, timing, valuation and performance of equity or other investments
|
|
▪
|
The likelihood that the market value of our impaired investments will recover
|
|
▪
|
Our intent to sell our investment securities prior to recovery of our cost basis, or the likelihood of such
|
|
▪
|
Expected cash requirements for unfunded commitments to certain investments, including capital calls
|
|
▪
|
Our overall management of interest rate risk, including managing the sensitivity of our interest-earning assets and interest-bearing liabilities to interest rates, and the impact to earnings from a change in interest rates
|
|
▪
|
The credit quality of our loan portfolio, including levels and trends of nonperforming loans, impaired loans, criticized loans and troubled debt restructurings
|
|
▪
|
The adequacy of reserves (including allowance for loan and lease losses) and the appropriateness of our methodology for calculating such reserves
|
|
▪
|
The level of loan and deposit balances
|
|
▪
|
The level of client investment fees and associated margins
|
|
▪
|
The profitability of our products and services
|
|
▪
|
Our strategic initiatives, including the expansion of operations in China, India, Israel, the UK and elsewhere (such as establishing our joint venture bank in China and a branch in the UK)
|
|
▪
|
The expansion and growth of our noninterest income sources
|
|
▪
|
Distributions of venture capital, private equity or debt fund investment proceeds; intentions to sell such fund investments
|
|
▪
|
The changes in, or adequacy of, our unrecognized tax benefits and any associated impact
|
|
▪
|
The extent to which counterparties, including those to our forward and option contracts, will perform their contractual obligations
|
|
▪
|
The effect of application of certain accounting pronouncements
|
|
▪
|
The effect of lawsuits and claims
|
|
▪
|
Regulatory developments, including the nature and timing of the adoption and effectiveness of new requirements under the Dodd-Frank Act (as defined below), Basel guidelines, and other applicable laws and regulations
|
|
▪
|
Continued strong growth in our lending business with record high average loan balances of $8.7 billion, an increase of $1.9 billion, or 27.6 percent.
|
|
▪
|
A provision for loan losses of $5.8 million, primarily attributable to net charge-offs of $4.3 million (or 0.20 percent of average total gross loans-annualized).
|
|
▪
|
Average deposit balances of $18.8 billion, an increase of $1.8 billion, or 10.7 percent. Average total client funds (including both average on-balance sheet deposits and off-balance sheet client investment funds) were $41.3 billion, an increase of $5.4 billion, or 15.1 percent.
|
|
▪
|
Net interest income (fully taxable equivalent basis) of $163.6 million, an increase of $12.2 million, or 8.1 percent, primarily due to an increase in interest income from loans attributable to growth in average balances of $1.9 billion. This increase was partially offset by lower yields earned on our overall loan portfolio. See “Results of Operations–Net Interest Income and Margin” for further details.
|
|
▪
|
Our net interest margin decreased by 5 basis points to 3.25 percent, primarily reflective of a 69 basis point decrease in the overall yield of our loan portfolio. This decrease was largely offset by strong growth in average loan balances, which has resulted in a favorable change in our mix of interest-earning assets.
|
|
▪
|
Core fee income (deposit service charges, letters of credit fees, credit card fees, client investment fees, and foreign exchange fees) of $36.6 million, an increase of $4.2 million, or 13.0 percent. This increase reflects increased client activity and continued growth in our business, primarily from foreign exchange fees, credit card fees and deposit service charges. See “Results of Operations—Noninterest Income” for a description and reconciliation of core fee income.
|
|
▪
|
Gains on investment securities, net of noncontrolling interests, of $5.1 million, compared to $0.5 million. The gains for both periods were primarily from our non-marketable fund investments. See “Results of Operations—Noninterest Income—Gains on Investment Securities, Net” for further details and a reconciliation of gains on investment securities, net of noncontrolling interests.
|
|
▪
|
Noninterest expense of $149.0 million, an increase of $17.0 million, or 12.9 percent. The increase was primarily driven by higher compensation expenses as a result of our strong financial performance and an increase in average full-time equivalent employees (“FTEs”), as well as increased premises and equipment and professional services expenses to support continued growth in our business and IT infrastructure initiatives. Average FTEs increased by 6.4 percent to 1,655 FTEs for the three months ended March 31, 2013, compared to 1,556 FTEs for the comparable 2012 period.
|
|
▪
|
Overall, our liquidity remained strong based on the attributes of our period end available-for-sale securities portfolio, which totaled $10.9 billion at March 31, 2013. Our available-for-sale securities portfolio continued to be a good source of liquidity as it was invested in high quality investments and generated steady monthly cash flows. Additionally, our available-for-sale securities portfolio continued to provide us with the ability to secure wholesale borrowings, as needed.
|
|
▪
|
Overall, SVB Financial and the Bank continued to maintain strong capital positions. All of our capital ratios increased from December 31, 2012 driven by strong quarterly earnings, while risk-weighted assets and average assets remained relatively flat. The Bank's Tier 1 leverage ratio increased by 29 basis points to 7.35 percent at March 31 2013, compared to 7.06 percent at December 31, 2012.
|
|
|
|
Three months ended March 31,
|
||||||||||
|
(Dollars in thousands, except per share data and ratios)
|
|
2013
|
|
2012
|
|
% Change
|
||||||
|
Income Statement:
|
|
|
|
|
|
|
|
|||||
|
Diluted earnings per share
|
|
$
|
0.90
|
|
|
$
|
0.78
|
|
|
15.4
|
|
%
|
|
Net income available to common stockholders
|
|
40,891
|
|
|
34,790
|
|
|
17.5
|
|
|
||
|
Net interest income
|
|
163,169
|
|
|
150,937
|
|
|
8.1
|
|
|
||
|
Net interest margin
|
|
3.25
|
%
|
|
3.30
|
%
|
|
(5
|
)
|
bps
|
||
|
Provision for loan losses
|
|
$
|
5,813
|
|
|
$
|
14,529
|
|
|
(60.0
|
)
|
%
|
|
Noninterest income
|
|
78,604
|
|
|
59,293
|
|
|
32.6
|
|
|
||
|
Noninterest expense
|
|
149,014
|
|
|
132,012
|
|
|
12.9
|
|
|
||
|
Non-GAAP noninterest income, net of noncontrolling interest (1)
|
|
56,114
|
|
|
51,375
|
|
|
9.2
|
|
|
||
|
Non-GAAP noninterest expense, net of noncontrolling interest (2)
|
|
146,154
|
|
|
129,194
|
|
|
13.1
|
|
|
||
|
Balance Sheet:
|
|
|
|
|
|
|
|
|||||
|
Average loans, net of unearned income
|
|
$
|
8,680,917
|
|
|
$
|
6,804,348
|
|
|
27.6
|
|
%
|
|
Average noninterest-bearing demand deposits
|
|
13,386,501
|
|
|
12,025,997
|
|
|
11.3
|
|
|
||
|
Average interest-bearing deposits
|
|
5,399,012
|
|
|
4,939,766
|
|
|
9.3
|
|
|
||
|
Average total deposits
|
|
18,785,513
|
|
|
16,965,763
|
|
|
10.7
|
|
|
||
|
Earnings Ratios:
|
|
|
|
|
|
|
|
|||||
|
Return on average assets (annualized) (3)
|
|
0.74
|
%
|
|
0.69
|
%
|
|
7.2
|
|
%
|
||
|
Return on average SVBFG stockholders’ equity (annualized) (4)
|
|
8.89
|
|
|
8.61
|
|
|
3.3
|
|
|
||
|
Asset Quality Ratios:
|
|
|
|
|
|
|
|
|||||
|
Allowance for loan losses as a percentage of total period-end gross loans
|
|
1.26
|
%
|
|
1.41
|
%
|
|
(15
|
)
|
bps
|
||
|
Allowance for loan losses for performing loans as a percentage of total gross performing loans
|
|
1.18
|
|
|
1.16
|
|
|
2
|
|
|
||
|
Gross loan charge-offs as a percentage of average total gross loans (annualized)
|
|
0.26
|
|
|
0.41
|
|
|
(15
|
)
|
|
||
|
Net loan charge-offs as a percentage of average total gross loans (annualized)
|
|
0.20
|
|
|
0.21
|
|
|
(1
|
)
|
|
||
|
Capital Ratios:
|
|
|
|
|
|
|
|
|||||
|
Total risk-based capital ratio
|
|
14.59
|
%
|
|
14.30
|
%
|
|
29
|
|
bps
|
||
|
Tier 1 risk-based capital ratio
|
|
13.30
|
|
|
12.91
|
|
|
39
|
|
|
||
|
Tier 1 leverage ratio
|
|
8.39
|
|
|
8.04
|
|
|
35
|
|
|
||
|
Tangible common equity to tangible assets (5)
|
|
8.26
|
|
|
7.87
|
|
|
39
|
|
|
||
|
Tangible common equity to risk-weighted assets (5)
|
|
13.94
|
|
|
13.54
|
|
|
40
|
|
|
||
|
Bank total risk-based capital ratio
|
|
13.01
|
|
|
12.59
|
|
|
42
|
|
|
||
|
Bank tier 1 risk-based capital ratio
|
|
11.70
|
|
|
11.16
|
|
|
54
|
|
|
||
|
Bank tier 1 leverage ratio
|
|
7.35
|
|
|
6.94
|
|
|
41
|
|
|
||
|
Bank tangible common equity to tangible assets (5)
|
|
7.62
|
|
|
7.16
|
|
|
46
|
|
|
||
|
Bank tangible common equity to risk-weighted assets (5)
|
|
12.45
|
|
|
11.94
|
|
|
51
|
|
|
||
|
Other Ratios:
|
|
|
|
|
|
|
|
|||||
|
Operating efficiency ratio (6)
|
|
61.52
|
%
|
|
62.65
|
%
|
|
(1.8
|
)
|
%
|
||
|
Non-GAAP operating efficiency ratio (2)
|
|
66.53
|
%
|
|
63.72
|
%
|
|
4.4
|
|
|
||
|
Book value per common share (7)
|
|
$
|
41.85
|
|
|
$
|
37.19
|
|
|
12.5
|
|
|
|
Other Statistics:
|
|
|
|
|
|
|
|
|||||
|
Average full-time equivalent employees
|
|
1,655
|
|
|
1,556
|
|
|
6.4
|
|
%
|
||
|
Period-end full-time equivalent employees
|
|
1,663
|
|
|
1,554
|
|
|
7.0
|
|
|
||
|
|
|
(1)
|
See “Results of Operations–Noninterest Income” for a description and reconciliation of non-GAAP noninterest income.
|
|
(2)
|
See “Results of Operations–Noninterest Expense” for a description and reconciliation of non-GAAP noninterest expense and non-GAAP operating efficiency ratio.
|
|
(3)
|
Ratio represents annualized consolidated net income available to common stockholders divided by quarterly average assets.
|
|
(4)
|
Ratio represents annualized consolidated net income available to common stockholders divided by quarterly average SVBFG stockholders’ equity.
|
|
(5)
|
See “Capital Resources–Capital Ratios” for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.
|
|
(6)
|
The operating efficiency ratio is calculated by dividing total noninterest expense by total taxable-equivalent net interest income plus noninterest income.
|
|
(7)
|
Book value per common share is calculated by dividing total SVBFG stockholders’ equity by total outstanding common shares at period-end.
|
|
|
|
2013 Compared to 2012
|
||||||||||
|
|
|
Three months ended March 31, increase (decrease) due to change in
|
||||||||||
|
(Dollars in thousands)
|
|
Volume
|
|
Rate
|
|
Total
|
||||||
|
Interest income:
|
|
|
|
|
|
|
||||||
|
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities
|
|
$
|
(314
|
)
|
|
$
|
(5
|
)
|
|
$
|
(319
|
)
|
|
Available-for-sale securities (taxable)
|
|
1,606
|
|
|
(3,229
|
)
|
|
(1,623
|
)
|
|||
|
Available-for-sale securities (non-taxable)
|
|
(134
|
)
|
|
(21
|
)
|
|
(155
|
)
|
|||
|
Loans, net of unearned income
|
|
26,984
|
|
|
(12,701
|
)
|
|
14,283
|
|
|||
|
Increase (decrease) in interest income, net
|
|
28,142
|
|
|
(15,956
|
)
|
|
12,186
|
|
|||
|
Interest expense:
|
|
|
|
|
|
|
||||||
|
NOW deposits
|
|
26
|
|
|
12
|
|
|
38
|
|
|||
|
Money market deposits
|
|
396
|
|
|
169
|
|
|
565
|
|
|||
|
Money market deposits in foreign offices
|
|
(9
|
)
|
|
—
|
|
|
(9
|
)
|
|||
|
Time deposits
|
|
21
|
|
|
(27
|
)
|
|
(6
|
)
|
|||
|
Sweep deposits in foreign offices
|
|
(18
|
)
|
|
—
|
|
|
(18
|
)
|
|||
|
Total increase in deposits expense
|
|
416
|
|
|
154
|
|
|
570
|
|
|||
|
Short-term borrowings
|
|
18
|
|
|
(1
|
)
|
|
17
|
|
|||
|
5.375% Senior Notes
|
|
—
|
|
|
6
|
|
|
6
|
|
|||
|
Junior Subordinated Debentures
|
|
(4
|
)
|
|
5
|
|
|
1
|
|
|||
|
5.70% Senior Notes
|
|
(503
|
)
|
|
—
|
|
|
(503
|
)
|
|||
|
6.05% Subordinated Notes
|
|
(2
|
)
|
|
(12
|
)
|
|
(14
|
)
|
|||
|
Other long-term debt
|
|
(69
|
)
|
|
—
|
|
|
(69
|
)
|
|||
|
Total decrease in borrowings expense
|
|
(560
|
)
|
|
(2
|
)
|
|
(562
|
)
|
|||
|
(Decrease) increase in interest expense, net
|
|
(144
|
)
|
|
152
|
|
|
8
|
|
|||
|
Increase (decrease) in net interest income
|
|
$
|
28,286
|
|
|
$
|
(16,108
|
)
|
|
$
|
12,178
|
|
|
•
|
Interest income
for the
three months
ended
March 31, 2013
increased by
$12.2 million
primarily due to:
|
|
◦
|
A
$14.3 million
increase in interest income on loans to $123.7 million for the three months ended March 31, 2013, compared to $109.5 million for the comparable 2012 period. This increase was reflective of an increase in average loan balances of $1.9 billion, partially offset by a decrease of 69 basis points in the overall yield on our loan portfolio. The decrease in yields was reflective of a continued change in the mix of our loans that are indexed to the national Prime rate instead of the SVB Prime rate. Additionally, loan yields were impacted by our success in growing our later stage client portfolio, which typically is benchmarked to three-month LIBOR and bears lower credit risk and therefore lower relative yield.
|
|
◦
|
A $1.8 million decrease in interest income on available-for-sale securities to $47.0 million for the three months ended March 31, 2013, compared to $48.8 million for the comparable 2012 period. The decrease was reflective of a decrease of 12 basis points in overall yields, partially offset by an increase related to higher average balances of $390 million. The decrease of 12 basis points in overall yields was comprised of a 19 basis points decrease in coupon yields, partially offset by a 7 basis points increase from lower premium amortization expense. The decrease in coupon yields was driven by paydowns of higher-yielding securities
b
eing reinvested in lower-yielding securities in the low interest rate environment. Premium amortization
|
|
•
|
Interest expense
for the
three months
ended
March 31, 2013
remained flat at $7.8 million. The items impacting interest expense were as follows:
|
|
◦
|
An increase in interest expense from interest-bearing deposits of $0.6 million, mainly attributable to an increase of $459 million in average interest-bearing deposits.
|
|
◦
|
A decrease in interest expense of
$0.6 million
related to our long-term debt, mainly attributable to a decrease of $0.5 million related to our 5.70% Senior Notes, which matured on June 1, 2012.
|
|
|
|
Three months ended March 31,
|
||||||||||||||||||||
|
|
|
2013
|
|
2012
|
||||||||||||||||||
|
(Dollars in thousands)
|
|
Average
Balance
|
|
Interest
Income/
Expense
|
|
Yield/
Rate
|
|
Average
Balance
|
|
Interest
Income/
Expense
|
|
Yield/
Rate
|
||||||||||
|
Interest-earning assets
:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Federal Reserve deposits, federal funds sold, securities purchased under agreements to resell and other short-term investment securities (1)
|
|
$
|
822,418
|
|
|
$
|
719
|
|
|
0.35
|
%
|
|
$
|
1,171,410
|
|
|
$
|
1,038
|
|
|
0.36
|
%
|
|
Available-for-sale securities: (2)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Taxable
|
|
10,803,735
|
|
|
45,752
|
|
|
1.72
|
|
|
10,405,476
|
|
|
47,375
|
|
|
1.83
|
|
||||
|
Non-taxable (3)
|
|
83,811
|
|
|
1,229
|
|
|
5.95
|
|
|
92,236
|
|
|
1,384
|
|
|
6.03
|
|
||||
|
Total loans, net of unearned income (4) (5)
|
|
8,680,917
|
|
|
123,744
|
|
|
5.78
|
|
|
6,804,348
|
|
|
109,461
|
|
|
6.47
|
|
||||
|
Total interest-earning assets
|
|
20,390,881
|
|
|
171,444
|
|
|
3.41
|
|
|
18,473,470
|
|
|
159,258
|
|
|
3.47
|
|
||||
|
Cash and due from banks
|
|
279,179
|
|
|
|
|
|
|
318,574
|
|
|
|
|
|
||||||||
|
Allowance for loan losses
|
|
(115,486
|
)
|
|
|
|
|
|
(93,840
|
)
|
|
|
|
|
||||||||
|
Other assets (6)
|
|
1,759,985
|
|
|
|
|
|
|
1,534,339
|
|
|
|
|
|
||||||||
|
Total assets
|
|
$
|
22,314,559
|
|
|
|
|
|
|
$
|
20,232,543
|
|
|
|
|
|
||||||
|
Funding sources
:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Interest-bearing liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
NOW deposits
|
|
$
|
135,436
|
|
|
$
|
117
|
|
|
0.35
|
%
|
|
$
|
104,498
|
|
|
$
|
79
|
|
|
0.30
|
%
|
|
Money market deposits
|
|
3,043,021
|
|
|
1,495
|
|
|
0.20
|
|
|
2,470,781
|
|
|
930
|
|
|
0.15
|
|
||||
|
Money market deposits in foreign offices
|
|
115,659
|
|
|
28
|
|
|
0.10
|
|
|
152,582
|
|
|
37
|
|
|
0.10
|
|
||||
|
Time deposits
|
|
172,401
|
|
|
173
|
|
|
0.41
|
|
|
152,621
|
|
|
179
|
|
|
0.47
|
|
||||
|
Sweep deposits in foreign offices
|
|
1,932,495
|
|
|
238
|
|
|
0.05
|
|
|
2,059,284
|
|
|
256
|
|
|
0.05
|
|
||||
|
Total interest-bearing deposits
|
|
5,399,012
|
|
|
2,051
|
|
|
0.15
|
|
|
4,939,766
|
|
|
1,481
|
|
|
0.12
|
|
||||
|
Short-term borrowings
|
|
74,939
|
|
|
28
|
|
|
0.15
|
|
|
27,415
|
|
|
11
|
|
|
0.16
|
|
||||
|
5.375% Senior Notes
|
|
348,013
|
|
|
4,821
|
|
|
5.62
|
|
|
347,810
|
|
|
4,815
|
|
|
5.57
|
|
||||
|
Junior Subordinated Debentures
|
|
55,181
|
|
|
832
|
|
|
6.11
|
|
|
55,357
|
|
|
831
|
|
|
6.04
|
|
||||
|
5.70% Senior Notes
|
|
—
|
|
|
—
|
|
|
—
|
|
|
143,485
|
|
|
503
|
|
|
1.41
|
|
||||
|
6.05% Subordinated Notes
|
|
54,282
|
|
|
113
|
|
|
0.84
|
|
|
55,252
|
|
|
127
|
|
|
0.92
|
|
||||
|
Other long-term debt
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,440
|
|
|
69
|
|
|
19.27
|
|
||||
|
Total interest-bearing liabilities
|
|
5,931,427
|
|
|
7,845
|
|
|
0.54
|
|
|
5,570,525
|
|
|
7,837
|
|
|
0.57
|
|
||||
|
Portion of noninterest-bearing funding sources
|
|
14,459,454
|
|
|
|
|
|
|
12,902,945
|
|
|
|
|
|
||||||||
|
Total funding sources
|
|
20,390,881
|
|
|
7,845
|
|
|
0.16
|
|
|
18,473,470
|
|
|
7,837
|
|
|
0.17
|
|
||||
|
Noninterest-bearing funding sources
:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Demand deposits
|
|
13,386,501
|
|
|
|
|
|
|
12,025,997
|
|
|
|
|
|
||||||||
|
Other liabilities
|
|
359,913
|
|
|
|
|
|
|
326,679
|
|
|
|
|
|
||||||||
|
SVBFG stockholders’ equity
|
|
1,866,310
|
|
|
|
|
|
|
1,624,256
|
|
|
|
|
|
||||||||
|
Noncontrolling interests
|
|
770,408
|
|
|
|
|
|
|
685,086
|
|
|
|
|
|
||||||||
|
Portion used to fund interest-earning assets
|
|
(14,459,454
|
)
|
|
|
|
|
|
(12,902,945
|
)
|
|
|
|
|
||||||||
|
Total liabilities, noncontrolling interest, and SVBFG stockholders’ equity
|
|
$
|
22,314,559
|
|
|
|
|
|
|
$
|
20,232,543
|
|
|
|
|
|
||||||
|
Net interest income and margin
|
|
|
|
$
|
163,599
|
|
|
3.25
|
%
|
|
|
|
$
|
151,421
|
|
|
3.30
|
%
|
||||
|
Total deposits
|
|
$
|
18,785,513
|
|
|
|
|
|
|
$
|
16,965,763
|
|
|
|
|
|
||||||
|
Reconciliation to reported net interest income
:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
Adjustments for taxable equivalent basis
|
|
|
|
(430
|
)
|
|
|
|
|
|
(484
|
)
|
|
|
||||||||
|
Net interest income, as reported
|
|
|
|
$
|
163,169
|
|
|
|
|
|
|
$
|
150,937
|
|
|
|
||||||
|
|
|
(1)
|
Includes average interest-earning deposits in other financial institutions of
$176 million
and
$332 million
for the
three months
ended
March 31, 2013
and
2012
, respectively. For the
three months
ended
March 31, 2013
and
2012
, balances also include
$375 million
and
$594 million
, respectively, deposited at the FRB, earning interest at the Federal Funds target rate.
|
|
(2)
|
Yields on available-for-sale securities are based on amortized cost, and therefore do not give effect to unrealized changes in fair value that are reflected in other comprehensive income.
|
|
(3)
|
Interest income on non-taxable available-for-sale securities is presented on a fully taxable-equivalent basis using the federal statutory income tax rate of 35.0 percent for all periods presented.
|
|
(4)
|
Nonaccrual loans are reflected in the average balances of loans.
|
|
(5)
|
Interest income includes loan fees of
$16.8 million
and
$17.1 million
for the
three months
ended
March 31, 2013
and
2012
, respectively.
|
|
(6)
|
Average investment securities of
$1.4 billion
and
$1.2 billion
for the
three months
ended
March 31, 2013
and
2012
, respectively, were classified as other assets as they were noninterest-earning assets. These investments primarily consisted of non-marketable securities.
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Allowance for loan losses, beginning balance
|
|
$
|
110,651
|
|
|
$
|
89,947
|
|
|
Provision for loan losses
|
|
5,813
|
|
|
14,529
|
|
||
|
Gross loan charge-offs
|
|
(5,626
|
)
|
|
(6,990
|
)
|
||
|
Loan recoveries
|
|
1,367
|
|
|
3,436
|
|
||
|
Allowance for loan losses, ending balance
|
|
$
|
112,205
|
|
|
$
|
100,922
|
|
|
Provision for loan losses as a percentage of total gross loans (annualized)
|
|
0.26
|
%
|
|
0.81
|
%
|
||
|
Gross loan charge-offs as a percentage of average total gross loans (annualized)
|
|
0.26
|
|
|
0.41
|
|
||
|
Net loan charge-offs as a percentage of average total gross loans (annualized)
|
|
0.20
|
|
|
0.21
|
|
||
|
Allowance for loan losses as a percentage of period-end total gross loans
|
|
1.26
|
|
|
1.41
|
|
||
|
Period-end total gross loans
|
|
$
|
8,922,829
|
|
|
$
|
7,180,779
|
|
|
Average total gross loans
|
|
8,755,699
|
|
|
6,861,122
|
|
||
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Core fee income:
|
|
|
|
|
|
|
|||||
|
Foreign exchange fees
|
|
$
|
13,448
|
|
|
$
|
12,103
|
|
|
11.1
|
%
|
|
Deposit service charges
|
|
8,793
|
|
|
8,096
|
|
|
8.6
|
|
||
|
Credit card fees
|
|
7,448
|
|
|
5,668
|
|
|
31.4
|
|
||
|
Letters of credit and standby letters of credit income
|
|
3,435
|
|
|
3,636
|
|
|
(5.5
|
)
|
||
|
Client investment fees
|
|
3,475
|
|
|
2,897
|
|
|
20.0
|
|
||
|
Total core fee income (1)
|
|
36,599
|
|
|
32,400
|
|
|
13.0
|
|
||
|
Gains on investment securities, net
|
|
27,438
|
|
|
7,839
|
|
|
NM
|
|
||
|
Gains on derivative instruments, net
|
|
11,040
|
|
|
5,976
|
|
|
84.7
|
|
||
|
Other
|
|
3,527
|
|
|
13,078
|
|
|
(73.0
|
)
|
||
|
Total noninterest income
|
|
$
|
78,604
|
|
|
$
|
59,293
|
|
|
32.6
|
|
|
|
|
(1)
|
The following table provides a reconciliation GAAP noninterest income to non-GAAP core fee income:
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
GAAP noninterest income (as reported)
|
|
$
|
78,604
|
|
|
$
|
59,293
|
|
|
32.6
|
%
|
|
Less: gains on investment securities, net
|
|
27,438
|
|
|
7,839
|
|
|
NM
|
|
||
|
Less: gains on derivative instruments, net
|
|
11,040
|
|
|
5,976
|
|
|
84.7
|
|
||
|
Less: other noninterest income
|
|
3,527
|
|
|
13,078
|
|
|
(73.0
|
)
|
||
|
Non-GAAP core fee income
|
|
$
|
36,599
|
|
|
$
|
32,400
|
|
|
13.0
|
|
|
|
|
|
|
Three months ended March 31,
|
|||||||||
|
Non-GAAP noninterest income, net of noncontrolling interests (Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
GAAP noninterest income (as reported)
|
|
$
|
78,604
|
|
|
$
|
59,293
|
|
|
32.6
|
%
|
|
Less: income attributable to noncontrolling interests, including carried interest
|
|
22,490
|
|
|
7,918
|
|
|
184.0
|
|
||
|
Non-GAAP noninterest income, net of noncontrolling interests
|
|
$
|
56,114
|
|
|
$
|
51,375
|
|
|
9.2
|
|
|
•
|
Gains of $2.4 million from our managed funds, primarily related to unrealized valuation increases and carried interest from three of our funds of funds.
|
|
•
|
Gains of $1.8 million from our investments in debt funds, driven by valuation increases from the investments within the funds.
|
|
(Dollars in thousands)
|
|
Managed
Funds of
Funds
|
|
Managed
Direct
Venture
Funds
|
|
Debt
Funds
|
|
Available-
For-Sale
Securities
|
|
Strategic
and Other
Investments
|
|
Total
|
||||||||||||
|
Three months ended March 31, 2013
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total gains (losses) on investment securities, net
|
|
$
|
22,802
|
|
|
$
|
1,856
|
|
|
$
|
1,753
|
|
|
$
|
(45
|
)
|
|
$
|
1,072
|
|
|
$
|
27,438
|
|
|
Less: income (losses) attributable to noncontrolling interests, including carried interest
|
|
20,802
|
|
|
1,496
|
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
22,296
|
|
||||||
|
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests
|
|
$
|
2,000
|
|
|
$
|
360
|
|
|
$
|
1,755
|
|
|
$
|
(45
|
)
|
|
$
|
1,072
|
|
|
$
|
5,142
|
|
|
Three months ended March 31, 2012
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Total gains (losses) on investment securities, net
|
|
$
|
12,305
|
|
|
$
|
(4,682
|
)
|
|
$
|
881
|
|
|
$
|
(874
|
)
|
|
$
|
209
|
|
|
$
|
7,839
|
|
|
Less: income (losses) attributable to noncontrolling interests, including carried interest
|
|
11,282
|
|
|
(3,959
|
)
|
|
15
|
|
|
—
|
|
|
—
|
|
|
7,338
|
|
||||||
|
Non-GAAP net gains (losses) on investment securities, net of noncontrolling interests
|
|
$
|
1,023
|
|
|
$
|
(723
|
)
|
|
$
|
866
|
|
|
$
|
(874
|
)
|
|
$
|
209
|
|
|
$
|
501
|
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Equity warrant assets (1)
|
|
|
|
|
|
|
|||||
|
Gains on exercises, net
|
|
$
|
814
|
|
|
$
|
2,941
|
|
|
(72.3
|
)%
|
|
Cancellations and expirations
|
|
(104
|
)
|
|
(569
|
)
|
|
(81.7
|
)
|
||
|
Changes in fair value
|
|
2,795
|
|
|
4,563
|
|
|
(38.7
|
)
|
||
|
Net gains on equity warrant assets
|
|
3,505
|
|
|
6,935
|
|
|
(49.5
|
)
|
||
|
Gains (losses) on foreign exchange forward contracts, net:
|
|
|
|
|
|
|
|||||
|
Gains on client foreign exchange forward contracts, net (2)
|
|
797
|
|
|
1,065
|
|
|
(25.2
|
)
|
||
|
Gains (losses) on internal foreign exchange forward contracts, net (3)
|
|
6,200
|
|
|
(2,051
|
)
|
|
NM
|
|
||
|
Total gains (losses) on foreign exchange forward contracts, net
|
|
6,997
|
|
|
(986
|
)
|
|
NM
|
|
||
|
Change in fair value of interest rate swaps
|
|
60
|
|
|
389
|
|
|
(84.6
|
)
|
||
|
Net gains (losses) on other derivatives (4)
|
|
478
|
|
|
(362
|
)
|
|
NM
|
|
||
|
Gains on derivative instruments, net
|
|
$
|
11,040
|
|
|
$
|
5,976
|
|
|
84.7
|
|
|
|
|
(1)
|
At
March 31, 2013
, we held warrants in
1,282
companies, compared to
1,192
companies at
March 31, 2012
.
|
|
(2)
|
Represents the net gains for foreign exchange forward contracts executed on behalf of clients.
|
|
(3)
|
Represents the change in the fair value of foreign exchange forward contracts used to economically reduce our foreign exchange exposure related to certain foreign currency denominated loans.
|
|
(4)
|
Primarily represents the change in fair value of loan conversion options held by SVB Financial. As of
March 31, 2013
, the loan conversion options related to
five
clients.
|
|
•
|
Net gains of
$6.2 million
on foreign exchange forward contracts hedging certain of our foreign currency denominated loans for the
three
months ended
March 31, 2013
, compared to net losses of
$2.1 million
for the comparable
2012
period. The net gains of $6.2 million for the
three
months ended March 31, 2013 were primarily attributable to the strengthening of the U.S. Dollar against the Euro and Pound Sterling. These gains were largely offset by net losses of $7.1 million from the revaluation of foreign currency denominated instruments that are included in the line item "Other" within noninterest income as noted below.
|
|
•
|
Net gains on equity warrant assets of
$3.5 million
for the three months ended
March 31, 2013
, compared to net gains of
$6.9 million
for the comparable
2012
period. The decrease was primarily reflective of higher levels of IPO and M&A activity in the first quarter of 2012.
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in millions)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Client directed investment assets (1)
|
|
$
|
6,898
|
|
|
$
|
7,556
|
|
|
(8.7
|
)%
|
|
Client investment assets under management
|
|
11,309
|
|
|
9,986
|
|
|
13.2
|
|
||
|
Sweep money market funds
|
|
4,283
|
|
|
1,341
|
|
|
NM
|
|
||
|
Total average client investment funds (2)
|
|
$
|
22,490
|
|
|
$
|
18,883
|
|
|
19.1
|
|
|
|
|
(1)
|
Comprised of mutual funds and Repurchase Agreement Program assets.
|
|
(2)
|
Client investment funds are maintained at third party financial institutions and are not recorded on our balance sheet.
|
|
(Dollars in millions)
|
|
March 31, 2013
|
|
December 31, 2012
|
|
% Change
|
|||
|
Client directed investment assets
|
|
6,943
|
|
|
7,604
|
|
|
(8.7
|
)%
|
|
Client investment assets under management
|
|
11,571
|
|
|
10,824
|
|
|
6.9
|
|
|
Sweep money market funds
|
|
4,467
|
|
|
4,085
|
|
|
9.4
|
|
|
Total period-end client investment funds
|
|
22,981
|
|
|
22,513
|
|
|
2.1
|
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Unused commitment fees
|
|
$
|
3,476
|
|
|
$
|
3,055
|
|
|
13.8
|
%
|
|
Fund management fees
|
|
2,769
|
|
|
2,828
|
|
|
(2.1
|
)
|
||
|
Service-based fee income (1)
|
|
1,804
|
|
|
2,374
|
|
|
(24.0
|
)
|
||
|
(Losses) gains on revaluation of foreign currency instruments (2)
|
|
(7,064
|
)
|
|
1,885
|
|
|
NM
|
|
||
|
Currency revaluation (losses) gains (3)
|
|
(55
|
)
|
|
615
|
|
|
(108.9
|
)
|
||
|
Other
|
|
2,597
|
|
|
2,321
|
|
|
11.9
|
|
||
|
Total other noninterest income
|
|
$
|
3,527
|
|
|
$
|
13,078
|
|
|
(73.0
|
)
|
|
|
|
(1)
|
Includes income from SVB Analytics.
|
|
(2)
|
Represents the revaluation of foreign currency denominated financial instruments issued and held by us, primarily loans, deposits and cash.
|
|
(3)
|
Includes the revaluation of foreign currency denominated assets of certain fund investments. Included in these amounts are gains of
$0.2 million
and
$0.6 million
for the
three
months ended
March 31, 2013
and 2012, respectively, attributable to noncontrolling interests calculated based on the ownership percentages of the noncontrolling interests.
|
|
•
|
Net losses on the revaluation of foreign currency instruments of
$7.1 million
for the
three
months ended
March 31, 2013
, compared to net gains of
$1.9 million
for the comparable
2012
period. The net losses of
$7.1 million
were largely offset by net gains of $6.2 million on internal foreign exchange forward contracts economically hedging certain of these instruments, which are included within noninterest income on the line item "gains on derivative instruments" as noted above.
|
|
•
|
Currency revaluation losses of
$0.1 million
for the
three
months ended
March 31, 2013
, compared to net gains
$0.6 million
for the comparable
2012
period. The net gains of $0.6 million for the three months ended March 31, 2012 were primarily due to the weakening of the U.S. Dollar against the Indian Rupee.
|
|
•
|
A decrease of $0.6 million in service-based fee income, primarily due to the sale of certain assets related to our equity management services business in the second quarter of 2012.
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Compensation and benefits
|
|
$
|
88,704
|
|
|
$
|
83,737
|
|
|
5.9
|
%
|
|
Professional services
|
|
17,160
|
|
|
14,607
|
|
|
17.5
|
|
||
|
Premises and equipment
|
|
10,725
|
|
|
7,564
|
|
|
41.8
|
|
||
|
Business development and travel
|
|
8,272
|
|
|
7,746
|
|
|
6.8
|
|
||
|
Net occupancy
|
|
5,767
|
|
|
5,623
|
|
|
2.6
|
|
||
|
FDIC assessments
|
|
3,382
|
|
|
2,498
|
|
|
35.4
|
|
||
|
Correspondent bank fees
|
|
3,055
|
|
|
2,688
|
|
|
13.7
|
|
||
|
Provision for (reduction of) unfunded credit commitments
|
|
2,014
|
|
|
(258
|
)
|
|
NM
|
|
||
|
Other
|
|
9,935
|
|
|
7,807
|
|
|
27.3
|
|
||
|
Total noninterest expense
|
|
$
|
149,014
|
|
|
$
|
132,012
|
|
|
12.9
|
|
|
|
|
Three months ended March 31,
|
|||||||||
|
Non-GAAP operating efficiency ratio, net of noncontrolling interests (Dollars in thousands, except ratios)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
GAAP noninterest expense
|
|
$
|
149,014
|
|
|
$
|
132,012
|
|
|
12.9
|
%
|
|
Less: amounts attributable to noncontrolling interests
|
|
2,860
|
|
|
2,818
|
|
|
1.5
|
|
||
|
Non-GAAP noninterest expense, net of noncontrolling interests
|
|
$
|
146,154
|
|
|
$
|
129,194
|
|
|
13.1
|
|
|
GAAP taxable equivalent net interest income
|
|
$
|
163,599
|
|
|
$
|
151,421
|
|
|
8.0
|
|
|
Less: income attributable to noncontrolling interests
|
|
24
|
|
|
43
|
|
|
(44.2
|
)
|
||
|
Non-GAAP taxable equivalent net interest income, net of noncontrolling interests
|
|
163,575
|
|
|
151,378
|
|
|
8.1
|
|
||
|
Non-GAAP noninterest income, net of noncontrolling interests
|
|
56,114
|
|
|
51,375
|
|
|
9.2
|
|
||
|
Non-GAAP taxable equivalent revenue, net of noncontrolling interests
|
|
$
|
219,689
|
|
|
$
|
202,753
|
|
|
8.4
|
|
|
Non-GAAP operating efficiency ratio (1)
|
|
66.53
|
%
|
|
63.72
|
%
|
|
4.4
|
|
||
|
|
|
(1)
|
The non-GAAP operating efficiency ratio is calculated by dividing non-GAAP noninterest expense by non-GAAP total taxable-equivalent income.
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Compensation and benefits
|
|
|
|
|
|
|
|||||
|
Salaries and wages
|
|
$
|
39,323
|
|
|
$
|
38,120
|
|
|
3.2
|
%
|
|
Incentive compensation & ESOP
|
|
22,193
|
|
|
21,147
|
|
|
4.9
|
|
||
|
Other employee benefits (1)
|
|
27,188
|
|
|
24,470
|
|
|
11.1
|
|
||
|
Total compensation and benefits
|
|
$
|
88,704
|
|
|
$
|
83,737
|
|
|
5.9
|
|
|
Period-end full-time equivalent employees
|
|
1,663
|
|
|
1,554
|
|
|
7.0
|
|
||
|
Average full-time equivalent employees
|
|
1,655
|
|
|
1,556
|
|
|
6.4
|
|
||
|
|
|
(1)
|
Other employee benefits includes employer payroll taxes, group health and life insurance, share-based compensation, 401(k), warrant and retention plans, agency fees and other employee related expenses.
|
|
•
|
An increase of $2.7 million in other employee benefits, primarily due to an increase in the number of average FTEs, as well as an increase in group health and life insurance expense. Average FTEs increased by
99
to
1,655
FTEs for the three months ended March 31, 2013, compared to
1,556
FTEs for the comparable
2012
period. The increase in headcount was primarily to support our product development, operational and sales and advisory teams, as well as to support our commercial banking operations and initiatives.
|
|
•
|
An increase of $2.2 million in total salaries and wages, incentive compensation and ESOP expenses, primarily due to an increase in the number of average FTEs.
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Telephone
|
|
$
|
1,557
|
|
|
$
|
1,784
|
|
|
(12.7
|
)%
|
|
Client services
|
|
1,935
|
|
|
1,253
|
|
|
54.4
|
|
||
|
Data processing services
|
|
1,912
|
|
|
1,405
|
|
|
36.1
|
|
||
|
Tax credit fund amortization
|
|
1,317
|
|
|
1,058
|
|
|
24.5
|
|
||
|
Postage and supplies
|
|
538
|
|
|
625
|
|
|
(13.9
|
)
|
||
|
Dues and publications
|
|
458
|
|
|
474
|
|
|
(3.4
|
)
|
||
|
Other
|
|
2,218
|
|
|
1,208
|
|
|
83.6
|
|
||
|
Total other noninterest expense
|
|
$
|
9,935
|
|
|
$
|
7,807
|
|
|
27.3
|
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Net interest income (1)
|
|
$
|
(24
|
)
|
|
$
|
(43
|
)
|
|
(44.2
|
)%
|
|
Noninterest income (1)
|
|
(23,288
|
)
|
|
(6,632
|
)
|
|
NM
|
|
||
|
Noninterest expense (1)
|
|
2,860
|
|
|
2,818
|
|
|
1.5
|
|
||
|
Carried interest (2)
|
|
798
|
|
|
(1,286
|
)
|
|
(162.1
|
)
|
||
|
Net income attributable to noncontrolling interests
|
|
$
|
(19,654
|
)
|
|
$
|
(5,143
|
)
|
|
NM
|
|
|
|
|
(1)
|
Represents noncontrolling interests’ share in net interest income, noninterest income and noninterest expense.
|
|
(2)
|
Represents the preferred allocation of income earned by the general partners or limited partners of certain consolidated funds.
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Net interest income
|
|
$
|
148,936
|
|
|
$
|
143,264
|
|
|
4.0
|
%
|
|
Provision for loan losses
|
|
(6,207
|
)
|
|
(13,236
|
)
|
|
(53.1
|
)
|
||
|
Noninterest income
|
|
46,541
|
|
|
39,928
|
|
|
16.6
|
|
||
|
Noninterest expense
|
|
(105,578
|
)
|
|
(96,443
|
)
|
|
9.5
|
|
||
|
Income before income tax expense
|
|
$
|
83,692
|
|
|
$
|
73,513
|
|
|
13.8
|
|
|
Total average loans, net of unearned income
|
|
$
|
7,868,587
|
|
|
$
|
6,031,356
|
|
|
30.5
|
|
|
Total average assets
|
|
20,463,477
|
|
|
18,556,741
|
|
|
10.3
|
|
||
|
Total average deposits
|
|
18,302,877
|
|
|
16,702,114
|
|
|
9.6
|
|
||
|
|
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Net interest income
|
|
$
|
6,104
|
|
|
$
|
4,965
|
|
|
22.9
|
%
|
|
Reduction of (provision for) loan losses
|
|
394
|
|
|
(1,293
|
)
|
|
(130.5
|
)
|
||
|
Noninterest income
|
|
234
|
|
|
157
|
|
|
49.0
|
|
||
|
Noninterest expense
|
|
(3,461
|
)
|
|
(3,126
|
)
|
|
10.7
|
|
||
|
Income before income tax expense
|
|
$
|
3,271
|
|
|
$
|
703
|
|
|
NM
|
|
|
Total average loans, net of unearned income
|
|
$
|
844,807
|
|
|
$
|
737,968
|
|
|
14.5
|
|
|
Total average assets
|
|
853,932
|
|
|
741,962
|
|
|
15.1
|
|
||
|
Total average deposits
|
|
470,673
|
|
|
240,500
|
|
|
95.7
|
|
||
|
|
|
Three months ended March 31,
|
|||||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
|
% Change
|
|||||
|
Net interest income
|
|
$
|
1
|
|
|
$
|
7
|
|
|
(85.7
|
)%
|
|
Noninterest income
|
|
5,441
|
|
|
3,587
|
|
|
51.7
|
|
||
|
Noninterest expense
|
|
(2,386
|
)
|
|
(2,536
|
)
|
|
(5.9
|
)
|
||
|
Income before income tax expense
|
|
$
|
3,056
|
|
|
$
|
1,058
|
|
|
188.8
|
|
|
Total average assets
|
|
$
|
238,743
|
|
|
$
|
260,127
|
|
|
(8.2
|
)
|
|
|
|
•
|
Net gains on investment securities of
$3.0 million
for the
three
months ended
March 31, 2013
, compared to net gains of
$0.6 million
for the comparable
2012
period. The net gains on investment securities of
$3.0 million
for the three months ended
March 31, 2013
were primarily driven by unrealized valuation increases and carried interest from three of our managed funds of funds.
|
|
•
|
Fund management fees of
$2.8 million
for both the
three
months ended
March 31, 2013
and
2012
.
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||||
|
(Dollars in thousands)
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG
|
|
Carrying value
(as reported)
|
|
Amount attributable
to SVBFG
|
||||||||
|
Non-marketable securities (fair value accounting):
|
|
|
|
|
|
|
|
|
||||||||
|
Venture capital and private equity fund investments (1)
|
|
$
|
701,076
|
|
|
$
|
77,282
|
|
|
$
|
665,921
|
|
|
$
|
75,893
|
|
|
Other venture capital investments (2)
|
|
124,786
|
|
|
8,647
|
|
|
127,091
|
|
|
8,962
|
|
||||
|
Non-marketable securities (equity method accounting):
|
|
|
|
|
|
|
|
|
||||||||
|
Other investments
|
|
140,607
|
|
|
140,607
|
|
|
139,330
|
|
|
139,330
|
|
||||
|
Low income housing tax credit funds
|
|
69,263
|
|
|
69,263
|
|
|
70,318
|
|
|
70,318
|
|
||||
|
Non-marketable securities (cost method accounting):
|
|
|
|
|
|
|
|
|
||||||||
|
Venture capital and private equity fund investments
|
|
160,870
|
|
|
160,870
|
|
|
161,884
|
|
|
161,884
|
|
||||
|
Other investments
|
|
19,186
|
|
|
19,186
|
|
|
19,721
|
|
|
19,721
|
|
||||
|
Total non-marketable securities
|
|
$
|
1,215,788
|
|
|
$
|
475,855
|
|
|
$
|
1,184,265
|
|
|
$
|
476,108
|
|
|
|
|
(1)
|
The following table shows the amounts of venture capital and private equity fund investments held by the following consolidated funds and amounts attributable to SVBFG for each fund at
March 31, 2013
and
December 31, 2012
:
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||||
|
(Dollars in thousands)
|
|
Carrying value
(as reported)
|
|
Amount
attributable
to SVBFG
|
|
Carrying value
(as reported)
|
|
Amount
attributable
to SVBFG
|
||||||||
|
SVB Strategic Investors Fund, LP
|
|
$
|
32,142
|
|
|
$
|
4,037
|
|
|
$
|
32,850
|
|
|
$
|
4,126
|
|
|
SVB Strategic Investors Fund II, LP
|
|
92,834
|
|
|
7,957
|
|
|
91,294
|
|
|
7,825
|
|
||||
|
SVB Strategic Investors Fund III, LP
|
|
212,392
|
|
|
12,469
|
|
|
209,696
|
|
|
12,311
|
|
||||
|
SVB Strategic Investors Fund IV, LP
|
|
189,369
|
|
|
9,468
|
|
|
169,931
|
|
|
8,497
|
|
||||
|
Strategic Investors Fund V Funds
|
|
51,985
|
|
|
149
|
|
|
40,622
|
|
|
112
|
|
||||
|
SVB Capital Preferred Return Fund, LP
|
|
54,919
|
|
|
12,953
|
|
|
53,643
|
|
|
12,652
|
|
||||
|
SVB Capital—NT Growth Partners, LP
|
|
59,835
|
|
|
23,729
|
|
|
60,120
|
|
|
23,842
|
|
||||
|
SVB Capital Partners II, LP
|
|
1,138
|
|
|
58
|
|
|
1,303
|
|
|
66
|
|
||||
|
Other private equity fund
|
|
6,462
|
|
|
6,462
|
|
|
6,462
|
|
|
6,462
|
|
||||
|
Total venture capital and private equity fund investments
|
|
$
|
701,076
|
|
|
$
|
77,282
|
|
|
$
|
665,921
|
|
|
$
|
75,893
|
|
|
(2)
|
The following table shows the amounts of other venture capital investments held by the following consolidated funds and amounts attributable to SVBFG for each fund at
March 31, 2013
and
December 31, 2012
:
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||||
|
(Dollars in thousands)
|
|
Carrying value
(as reported)
|
|
Amount
attributable
to SVBFG
|
|
Carrying value
(as reported)
|
|
Amount
attributable
to SVBFG
|
||||||||
|
Silicon Valley BancVentures, LP
|
|
$
|
39,971
|
|
|
$
|
4,275
|
|
|
$
|
43,493
|
|
|
$
|
4,652
|
|
|
SVB Capital Partners II, LP
|
|
80,966
|
|
|
4,112
|
|
|
79,761
|
|
|
4,051
|
|
||||
|
SVB Capital Shanghai Yangpu Venture Capital Fund
|
|
3,849
|
|
|
260
|
|
|
3,837
|
|
|
259
|
|
||||
|
Total other venture capital investments
|
|
$
|
124,786
|
|
|
$
|
8,647
|
|
|
$
|
127,091
|
|
|
$
|
8,962
|
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||
|
(Dollars in thousands)
|
|
Amount
|
|
Percentage
|
|
Amount
|
|
Percentage
|
||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
||||||
|
Software
|
|
$
|
3,490,963
|
|
|
39.1
|
%
|
|
$
|
3,293,899
|
|
|
36.5
|
%
|
|
Hardware
|
|
1,233,181
|
|
|
13.8
|
|
|
1,129,484
|
|
|
12.5
|
|
||
|
Venture capital/private equity
|
|
1,335,561
|
|
|
15.0
|
|
|
1,749,903
|
|
|
19.4
|
|
||
|
Life science
|
|
1,028,275
|
|
|
11.5
|
|
|
1,076,792
|
|
|
11.9
|
|
||
|
Premium wine
|
|
140,439
|
|
|
1.6
|
|
|
144,937
|
|
|
1.6
|
|
||
|
Other
|
|
345,630
|
|
|
3.9
|
|
|
318,588
|
|
|
3.5
|
|
||
|
Total commercial loans
|
|
7,574,049
|
|
|
84.9
|
|
|
7,713,603
|
|
|
85.5
|
|
||
|
Real estate secured loans:
|
|
|
|
|
|
|
|
|
||||||
|
Premium wine
|
|
465,947
|
|
|
5.2
|
|
|
414,347
|
|
|
4.6
|
|
||
|
Consumer loans
|
|
724,849
|
|
|
8.1
|
|
|
685,493
|
|
|
7.6
|
|
||
|
Total real estate secured loans
|
|
1,190,796
|
|
|
13.3
|
|
|
1,099,840
|
|
|
12.2
|
|
||
|
Construction loans
|
|
58,726
|
|
|
0.7
|
|
|
65,726
|
|
|
0.7
|
|
||
|
Consumer loans
|
|
99,258
|
|
|
1.1
|
|
|
145,079
|
|
|
1.6
|
|
||
|
Total gross loans
|
|
$
|
8,922,829
|
|
|
100.0
|
%
|
|
$
|
9,024,248
|
|
|
100.0
|
%
|
|
|
|
March 31, 2013
|
||||||||||||||||||||||
|
(Dollars in thousands)
|
|
Less than
Five Million
|
|
Five to Ten
Million
|
|
Ten to Twenty
Million
|
|
Twenty to Thirty Million
|
|
Thirty Million
or More
|
|
Total
|
||||||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Software
|
|
$
|
1,059,799
|
|
|
$
|
482,095
|
|
|
$
|
732,226
|
|
|
$
|
833,598
|
|
|
$
|
383,245
|
|
|
$
|
3,490,963
|
|
|
Hardware
|
|
300,201
|
|
|
265,556
|
|
|
121,781
|
|
|
254,908
|
|
|
290,735
|
|
|
1,233,181
|
|
||||||
|
Venture capital/private equity
|
|
264,054
|
|
|
160,364
|
|
|
326,635
|
|
|
192,140
|
|
|
392,368
|
|
|
1,335,561
|
|
||||||
|
Life science
|
|
281,225
|
|
|
211,830
|
|
|
193,323
|
|
|
190,696
|
|
|
151,201
|
|
|
1,028,275
|
|
||||||
|
Premium wine (1)
|
|
64,483
|
|
|
36,033
|
|
|
17,256
|
|
|
7,125
|
|
|
15,542
|
|
|
140,439
|
|
||||||
|
Other
|
|
117,462
|
|
|
56,990
|
|
|
51,166
|
|
|
85,012
|
|
|
35,000
|
|
|
345,630
|
|
||||||
|
Commercial loans
|
|
2,087,224
|
|
|
1,212,868
|
|
|
1,442,387
|
|
|
1,563,479
|
|
|
1,268,091
|
|
|
7,574,049
|
|
||||||
|
Real estate secured loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Premium wine (1)
|
|
118,420
|
|
|
124,062
|
|
|
114,620
|
|
|
62,167
|
|
|
46,678
|
|
|
465,947
|
|
||||||
|
Consumer loans (2)
|
|
603,509
|
|
|
77,823
|
|
|
43,517
|
|
|
—
|
|
|
—
|
|
|
724,849
|
|
||||||
|
Real estate secured loans
|
|
721,929
|
|
|
201,885
|
|
|
158,137
|
|
|
62,167
|
|
|
46,678
|
|
|
1,190,796
|
|
||||||
|
Construction loans
|
|
17,828
|
|
|
40,898
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
58,726
|
|
||||||
|
Consumer loans (2)
|
|
33,757
|
|
|
22,631
|
|
|
870
|
|
|
—
|
|
|
42,000
|
|
|
99,258
|
|
||||||
|
Total gross loans
|
|
$
|
2,860,738
|
|
|
$
|
1,478,282
|
|
|
$
|
1,601,394
|
|
|
$
|
1,625,646
|
|
|
$
|
1,356,769
|
|
|
$
|
8,922,829
|
|
|
|
|
(1)
|
Premium wine clients can have loan balances included in both commercial loans and real estate secured loans, the total of which are used for the breakout of the above categories.
|
|
(2)
|
Consumer loan clients have loan balances included in both real estate secured loans and other consumer loans, the total of which are used for the breakout of the above categories.
|
|
|
|
December 31, 2012
|
||||||||||||||||||||||
|
(Dollars in thousands)
|
|
Less than
Five Million
|
|
Five to Ten
Million
|
|
Ten to Twenty
Million
|
|
Twenty to Thirty Million
|
|
Thirty Million
or More
|
|
Total
|
||||||||||||
|
Commercial loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Software
|
|
$
|
991,011
|
|
|
$
|
575,721
|
|
|
$
|
601,400
|
|
|
$
|
731,840
|
|
|
$
|
393,927
|
|
|
$
|
3,293,899
|
|
|
Hardware
|
|
295,981
|
|
|
203,813
|
|
|
176,854
|
|
|
229,913
|
|
|
222,923
|
|
|
1,129,484
|
|
||||||
|
Venture capital/private equity
|
|
298,299
|
|
|
194,717
|
|
|
285,914
|
|
|
301,061
|
|
|
669,912
|
|
|
1,749,903
|
|
||||||
|
Life science
|
|
280,100
|
|
|
221,399
|
|
|
223,104
|
|
|
200,056
|
|
|
152,133
|
|
|
1,076,792
|
|
||||||
|
Premium wine (1)
|
|
71,472
|
|
|
24,986
|
|
|
41,979
|
|
|
6,500
|
|
|
—
|
|
|
144,937
|
|
||||||
|
Other
|
|
89,703
|
|
|
56,078
|
|
|
55,608
|
|
|
54,620
|
|
|
62,579
|
|
|
318,588
|
|
||||||
|
Commercial loans
|
|
2,026,566
|
|
|
1,276,714
|
|
|
1,384,859
|
|
|
1,523,990
|
|
|
1,501,474
|
|
|
7,713,603
|
|
||||||
|
Real estate secured loans:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
|
Premium wine (1)
|
|
101,501
|
|
|
110,080
|
|
|
128,950
|
|
|
42,316
|
|
|
31,500
|
|
|
414,347
|
|
||||||
|
Consumer loans (2)
|
|
563,319
|
|
|
78,531
|
|
|
43,643
|
|
|
—
|
|
|
—
|
|
|
685,493
|
|
||||||
|
Real estate secured loans
|
|
664,820
|
|
|
188,611
|
|
|
172,593
|
|
|
42,316
|
|
|
31,500
|
|
|
1,099,840
|
|
||||||
|
Construction loans
|
|
17,182
|
|
|
33,928
|
|
|
14,616
|
|
|
—
|
|
|
—
|
|
|
65,726
|
|
||||||
|
Consumer loans (2)
|
|
29,436
|
|
|
46,152
|
|
|
24,491
|
|
|
—
|
|
|
45,000
|
|
|
145,079
|
|
||||||
|
Total gross loans
|
|
$
|
2,738,004
|
|
|
$
|
1,545,405
|
|
|
$
|
1,596,559
|
|
|
$
|
1,566,306
|
|
|
$
|
1,577,974
|
|
|
$
|
9,024,248
|
|
|
|
|
(1)
|
Premium wine clients can have loan balances included in both commercial loans and real estate secured loans, the total of which are used for the breakout of the above categories.
|
|
(2)
|
Consumer loan clients have loan balances included in both real estate secured loans and other consumer loans, the total of which are used for the breakout of the above categories.
|
|
(Dollars in thousands)
|
|
March 31, 2013
|
|
December 31, 2012
|
||||
|
Gross nonperforming, past due, and restructured loans:
|
|
|
|
|
||||
|
Loans past due 90 days or more still accruing interest
|
|
$
|
36
|
|
|
$
|
19
|
|
|
Impaired loans
|
|
44,346
|
|
|
38,279
|
|
||
|
Performing TDRs
|
|
1,522
|
|
|
734
|
|
||
|
Nonperforming loans as a percentage of total gross loans
|
|
0.50
|
%
|
|
0.42
|
%
|
||
|
Nonperforming assets as a percentage of total assets
|
|
0.19
|
|
|
0.17
|
%
|
||
|
Allowance for loan losses
|
|
$
|
112,205
|
|
|
$
|
110,651
|
|
|
As a percentage of total gross loans
|
|
1.26
|
%
|
|
1.23
|
%
|
||
|
As a percentage of total gross nonperforming loans
|
|
253.02
|
|
|
289.06
|
|
||
|
Allowance for loan losses for impaired loans
|
|
$
|
7,728
|
|
|
$
|
6,261
|
|
|
As a percentage of total gross loans
|
|
0.09
|
%
|
|
0.07
|
%
|
||
|
As a percentage of total gross nonperforming loans
|
|
17.43
|
|
|
16.36
|
|
||
|
Allowance for loan losses for total gross performing loans
|
|
$
|
104,477
|
|
|
$
|
104,390
|
|
|
As a percentage of total gross loans
|
|
1.17
|
%
|
|
1.16
|
%
|
||
|
As a percentage of total gross performing loans
|
|
1.18
|
|
|
1.16
|
|
||
|
Total gross loans
|
|
$
|
8,922,829
|
|
|
$
|
9,024,248
|
|
|
Total gross performing loans
|
|
8,878,483
|
|
|
8,985,969
|
|
||
|
Reserve for unfunded credit commitments (1)
|
|
24,300
|
|
|
22,299
|
|
||
|
As a percentage of total unfunded credit commitments
|
|
0.26
|
%
|
|
0.26
|
%
|
||
|
Total unfunded credit commitments (2)
|
|
$
|
9,170,337
|
|
|
$
|
8,610,791
|
|
|
|
|
(1)
|
The “Reserve for unfunded credit commitments” is included as a component of other liabilities. See “Provision for Unfunded Credit Commitments” above for a discussion of the changes to the reserve.
|
|
(2)
|
Includes unfunded loan commitments and letters of credit.
|
|
(Dollars in thousands)
|
|
March 31, 2013
|
|
December 31, 2012
|
|
% Change
|
|||||
|
Derivative assets, gross (1)
|
|
$
|
96,773
|
|
|
$
|
98,266
|
|
|
(1.5
|
)%
|
|
Accrued interest receivable
|
|
64,375
|
|
|
64,167
|
|
|
0.3
|
|
||
|
FHLB and FRB stock
|
|
39,806
|
|
|
39,806
|
|
|
—
|
|
||
|
Foreign exchange spot contract assets, gross
|
|
84,096
|
|
|
42,653
|
|
|
97.2
|
|
||
|
Accounts receivable
|
|
14,721
|
|
|
15,650
|
|
|
(5.9
|
)
|
||
|
Prepaid FDIC assessments
|
|
230
|
|
|
461
|
|
|
(50.1
|
)
|
||
|
Other assets
|
|
54,401
|
|
|
65,868
|
|
|
(17.4
|
)
|
||
|
Total accrued interest receivable and other assets
|
|
$
|
354,402
|
|
|
$
|
326,871
|
|
|
8.4
|
|
|
|
|
(1)
|
See “Derivatives” section below.
|
|
(Dollars in thousands)
|
|
March 31, 2013
|
|
December 31, 2012
|
|
% Change
|
|||||
|
Assets:
|
|
|
|
|
|
|
|||||
|
Equity warrant assets
|
|
$
|
72,333
|
|
|
$
|
74,272
|
|
|
(2.6
|
)%
|
|
Foreign exchange forward and option contracts
|
|
13,752
|
|
|
13,541
|
|
|
1.6
|
|
||
|
Interest rate swaps
|
|
8,506
|
|
|
9,005
|
|
|
(5.5
|
)
|
||
|
Loan conversion options
|
|
1,529
|
|
|
890
|
|
|
71.8
|
|
||
|
Client interest rate derivatives
|
|
653
|
|
|
558
|
|
|
17.0
|
|
||
|
Total derivative assets
|
|
$
|
96,773
|
|
|
$
|
98,266
|
|
|
(1.5
|
)
|
|
Liabilities:
|
|
|
|
|
|
|
|
||||
|
Foreign exchange forward and option contracts
|
|
$
|
(11,513
|
)
|
|
$
|
(12,847
|
)
|
|
(10.4
|
)
|
|
Client interest rate derivatives
|
|
(691
|
)
|
|
(590
|
)
|
|
17.1
|
|
||
|
Total derivative liabilities
|
|
$
|
(12,204
|
)
|
|
$
|
(13,437
|
)
|
|
(9.2
|
)
|
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Balance, beginning of period
|
|
$
|
74,272
|
|
|
$
|
66,953
|
|
|
New equity warrant assets
|
|
2,503
|
|
|
2,608
|
|
||
|
Non-cash increases in fair value
|
|
2,795
|
|
|
4,563
|
|
||
|
Exercised equity warrant assets
|
|
(7,133
|
)
|
|
(2,151
|
)
|
||
|
Terminated equity warrant assets
|
|
(104
|
)
|
|
(569
|
)
|
||
|
Balance, end of period
|
|
$
|
72,333
|
|
|
$
|
71,404
|
|
|
(Dollars in thousands)
|
|
March 31, 2013
|
|
December 31, 2012
|
|
% Change
|
|||||
|
Foreign exchange spot contract liabilities, gross
|
|
$
|
125,846
|
|
|
$
|
57,868
|
|
|
117.5
|
%
|
|
Accrued compensation
|
|
31,834
|
|
|
94,209
|
|
|
(66.2
|
)
|
||
|
Reserve for unfunded credit commitments
|
|
24,300
|
|
|
22,299
|
|
|
9.0
|
|
||
|
Derivative liabilities, gross (1)
|
|
12,204
|
|
|
13,437
|
|
|
(9.2
|
)
|
||
|
Deferred tax liabilities
|
|
15,614
|
|
|
25,580
|
|
|
(39.0
|
)
|
||
|
Other
|
|
149,582
|
|
|
147,173
|
|
|
1.6
|
|
||
|
Total other liabilities
|
|
$
|
359,380
|
|
|
$
|
360,566
|
|
|
(0.3
|
)
|
|
|
|
(1)
|
See “Derivatives” section above.
|
|
|
|
March 31, 2013
|
|
December 31, 2012
|
||||||||||||
|
(Dollars in thousands)
|
|
Total Balance
|
|
Level 3
|
|
Total Balance
|
|
Level 3
|
||||||||
|
Assets carried at fair value
|
|
$
|
11,840,976
|
|
|
$
|
891,908
|
|
|
$
|
12,244,783
|
|
|
$
|
859,141
|
|
|
As a percentage of total assets
|
|
51.9
|
%
|
|
3.9
|
%
|
|
53.8
|
%
|
|
3.8
|
%
|
||||
|
Liabilities carried at fair value
|
|
$
|
12,204
|
|
|
$
|
—
|
|
|
$
|
13,437
|
|
|
$
|
—
|
|
|
As a percentage of total liabilities
|
|
0.1
|
%
|
|
—
|
%
|
|
0.1
|
%
|
|
—
|
%
|
||||
|
|
|
Level 1 and 2
|
|
Level 3
|
|
Level 1 and 2
|
|
Level 3
|
||||||||
|
Percentage of assets measured at fair value
|
|
92.5
|
%
|
|
7.5
|
%
|
|
93.0
|
%
|
|
7.0
|
%
|
||||
|
|
|
March 31, 2013
|
|
December 31, 2012
|
|
Minimum ratio to be
“Well Capitalized”
|
|
Minimum ratio to be
“Adequately Capitalized”
|
||||
|
SVB Financial:
|
|
|
|
|
|
|
|
|
||||
|
Total risk-based capital ratio
|
|
14.59
|
%
|
|
14.05
|
%
|
|
10.0
|
%
|
|
8.0
|
%
|
|
Tier 1 risk-based capital ratio
|
|
13.30
|
|
|
12.79
|
|
|
6.0
|
|
|
4.0
|
|
|
Tier 1 leverage ratio
|
|
8.39
|
|
|
8.06
|
|
|
N/A
|
|
|
4.0
|
|
|
Tangible common equity to tangible assets ratio (1)(2)
|
|
8.26
|
|
|
8.04
|
|
|
N/A
|
|
|
N/A
|
|
|
Tangible common equity to risk-weighted assets ratio (1)(2)
|
|
13.94
|
|
|
13.53
|
|
|
N/A
|
|
|
N/A
|
|
|
Bank:
|
|
|
|
|
|
|
|
|
||||
|
Total risk-based capital ratio
|
|
13.01
|
%
|
|
12.53
|
%
|
|
10.0
|
%
|
|
8.0
|
%
|
|
Tier 1 risk-based capital ratio
|
|
11.70
|
|
|
11.24
|
|
|
6.0
|
|
|
4.0
|
|
|
Tier 1 leverage ratio
|
|
7.35
|
|
|
7.06
|
|
|
5.0
|
|
|
4.0
|
|
|
Tangible common equity to tangible assets ratio (1)(2)
|
|
7.62
|
|
|
7.41
|
|
|
N/A
|
|
|
N/A
|
|
|
Tangible common equity to risk-weighted assets ratio (1)(2)
|
|
12.45
|
|
|
12.08
|
|
|
N/A
|
|
|
N/A
|
|
|
|
|
(1)
|
See below for a reconciliation of non-GAAP tangible common equity to tangible assets and tangible common equity to risk-weighted assets.
|
|
(2)
|
The FRB has not issued any minimum guidelines for the tangible common equity to tangible assets ratio or the tangible common equity to risk-weighted assets ratio. However, we believe these ratios provide meaningful supplemental information regarding our capital levels and are therefore provided above.
|
|
|
|
SVB Financial
|
|
Bank
|
||||||||||||
|
Non-GAAP tangible common equity and tangible assets (dollars in thousands, except ratios)
|
|
March 31,
2013 |
|
December 31,
2012 |
|
March 31,
2013 |
|
December 31,
2012 |
||||||||
|
GAAP SVBFG stockholders’ equity
|
|
$
|
1,882,219
|
|
|
$
|
1,830,555
|
|
|
$
|
1,637,365
|
|
|
$
|
1,591,643
|
|
|
Less:
|
|
|
|
|
|
|
|
|
||||||||
|
Intangible assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Tangible common equity
|
|
$
|
1,882,219
|
|
|
$
|
1,830,555
|
|
|
$
|
1,637,365
|
|
|
$
|
1,591,643
|
|
|
GAAP Total assets
|
|
$
|
22,796,000
|
|
|
$
|
22,766,123
|
|
|
$
|
21,487,859
|
|
|
$
|
21,471,111
|
|
|
Less:
|
|
|
|
|
|
|
|
|
||||||||
|
Intangible assets
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
|
Tangible assets
|
|
$
|
22,796,000
|
|
|
$
|
22,766,123
|
|
|
$
|
21,487,859
|
|
|
$
|
21,471,111
|
|
|
Risk-weighted assets
|
|
$
|
13,501,072
|
|
|
$
|
13,532,984
|
|
|
$
|
13,147,423
|
|
|
$
|
13,177,887
|
|
|
Tangible common equity to tangible assets
|
|
8.26
|
%
|
|
8.04
|
%
|
|
7.62
|
%
|
|
7.41
|
%
|
||||
|
Tangible common equity to risk-weighted assets
|
|
13.94
|
|
|
13.53
|
|
|
12.45
|
|
|
12.08
|
|
||||
|
|
|
Three months ended March 31,
|
||||||
|
(Dollars in thousands)
|
|
2013
|
|
2012
|
||||
|
Average cash and cash equivalents
|
|
$
|
1,101,597
|
|
|
$
|
1,489,984
|
|
|
Percentage of total average assets
|
|
4.9
|
%
|
|
7.4
|
%
|
||
|
Net cash used for operating activities
|
|
$
|
(1,044
|
)
|
|
$
|
(10,872
|
)
|
|
Net cash provided by (used for) investing activities
|
|
532,326
|
|
|
(1,148,180
|
)
|
||
|
Net cash (used for) provided by financing activities
|
|
(21,016
|
)
|
|
894,728
|
|
||
|
Net increase (decrease) in cash and cash equivalents
|
|
$
|
510,266
|
|
|
$
|
(264,324
|
)
|
|
|
|
Estimated
|
|
Estimated Increase In EVE
|
|
Estimated
|
|
Estimated Increase/
(Decrease) In NII
|
||||||||||||||
|
Change in interest rates (basis points)
|
|
EVE
|
|
Amount
|
|
Percent
|
|
NII
|
|
Amount
|
|
Percent
|
||||||||||
|
|
|
(Dollars in thousands)
|
||||||||||||||||||||
|
March 31, 2013:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
+200
|
|
$
|
3,487,516
|
|
|
$
|
499,318
|
|
|
16.7
|
|
|
$
|
832,813
|
|
|
$
|
150,933
|
|
|
22.1
|
%
|
|
+100
|
|
3,154,121
|
|
|
165,923
|
|
|
5.6
|
|
|
749,165
|
|
|
67,285
|
|
|
9.9
|
|
||||
|
—
|
|
2,988,198
|
|
|
—
|
|
|
—
|
|
|
681,880
|
|
|
—
|
|
|
—
|
|
||||
|
-100
|
|
3,133,881
|
|
|
145,683
|
|
|
4.9
|
|
|
655,603
|
|
|
(26,277
|
)
|
|
(3.9
|
)
|
||||
|
-200
|
|
3,168,485
|
|
|
180,287
|
|
|
6.0
|
|
|
654,695
|
|
|
(27,185
|
)
|
|
(4.0
|
)
|
||||
|
December 31, 2012:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
+200
|
|
$
|
3,176,231
|
|
|
$
|
345,925
|
|
|
12.2
|
%
|
|
$
|
834,208
|
|
|
$
|
137,021
|
|
|
19.7
|
%
|
|
+100
|
|
2,862,361
|
|
|
32,055
|
|
|
1.1
|
|
|
757,662
|
|
|
60,475
|
|
|
8.7
|
|
||||
|
—
|
|
2,830,306
|
|
|
—
|
|
|
—
|
|
|
697,187
|
|
|
—
|
|
|
—
|
|
||||
|
-100
|
|
2,981,216
|
|
|
150,910
|
|
|
5.3
|
|
|
671,976
|
|
|
(25,211
|
)
|
|
(3.6
|
)
|
||||
|
-200
|
|
3,012,121
|
|
|
181,815
|
|
|
6.4
|
|
|
670,445
|
|
|
(26,742
|
)
|
|
(3.8
|
)
|
||||
|
|
|
SVB Financial Group
|
|
|
|
|
|
Date: May 10, 2013
|
|
/s/ MICHAEL DESCHENEAUX
|
|
|
|
Michael Descheneaux
|
|
|
|
Chief Financial Officer
|
|
|
|
(Principal Financial Officer)
|
|
|
|
|
|
|
|
SVB Financial Group
|
|
|
|
|
|
Date: May 10, 2013
|
|
/s/ KAMRAN HUSAIN
|
|
|
|
Kamran Husain
|
|
|
|
Chief Accounting Officer
|
|
|
|
(Principal Accounting Officer)
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
Incorporated by Reference
|
|
Filed
Herewith
|
||||||
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||||
|
3.1
|
|
Restated Certificate of Incorporation
|
|
8-K
|
|
000-15637
|
|
3.1
|
|
May 31, 2005
|
|
|
|
3.2
|
|
Amended and Restated Bylaws
|
|
8-K
|
|
000-15637
|
|
3.2
|
|
July 27, 2010
|
|
|
|
3.3
|
|
Certificate of Designation of Rights, Preferences and Privileges of Series A Participating Preferred Stock
|
|
8-K
|
|
000-15637
|
|
3.3
|
|
December 8, 2008
|
|
|
|
3.4
|
|
Certificate of Designations of Fixed Rate Cumulative Perpetual Preferred Stock, Series B
|
|
8-K
|
|
000-15637
|
|
3.4
|
|
December 15, 2008
|
|
|
|
4.1
|
|
Junior Subordinated Indenture, dated as of October 30, 2003 between SVB Financial and Wilmington Trust Company, as trustee
|
|
8-K
|
|
000-15637
|
|
4.12
|
|
November 19, 2003
|
|
|
|
4.2
|
|
7.0% Junior Subordinated Deferrable Interest Debenture due October 15, 2033 of SVB Financial
|
|
8-K
|
|
000-15637
|
|
4.13
|
|
November 19, 2003
|
|
|
|
4.3
|
|
Amended and Restated Trust Agreement, dated as of October 30, 2003, by and among SVB Financial as depositor, Wilmington Trust Company as property trustee, Wilmington Trust Company as Delaware trustee, and the Administrative Trustees named therein
|
|
8-K
|
|
000-15637
|
|
4.14
|
|
November 19, 2003
|
|
|
|
4.4
|
|
Certificate Evidencing 7% Cumulative Trust Preferred Securities of SVB Capital II, dated October 30, 2003
|
|
8-K
|
|
000-15637
|
|
4.15
|
|
November 19, 2003
|
|
|
|
4.5
|
|
Guarantee Agreement, dated October 30, 2003, between SVB Financial and Wilmington Trust Company, as trustee
|
|
8-K
|
|
000-15637
|
|
4.16
|
|
November 19, 2003
|
|
|
|
4.6
|
|
Agreement as to Expenses and Liabilities, dated as of October 30, 2003, between SVB Financial and SVB Capital II
|
|
8-K
|
|
000-15637
|
|
4.17
|
|
November 19, 2003
|
|
|
|
4.7
|
|
Certificate Evidencing 7% Common Securities of SVB Capital II, dated October 30, 2003
|
|
8-K
|
|
000-15637
|
|
4.18
|
|
November 19, 2003
|
|
|
|
4.8
|
|
Officers’ Certificate and Company Order, dated October 30, 2003, relating to the 7.0% Junior Subordinated Deferrable Interest Debentures due October 15, 2033
|
|
8-K
|
|
000-15637
|
|
4.19
|
|
November 19, 2003
|
|
|
|
4.9
|
|
Amended and Restated Preferred Stock Rights Agreement, dated as of January 29, 2004, between SVB Financial and Wells Fargo Bank Minnesota, N.A.
|
|
8-A12G/A
|
|
000-15637
|
|
4.20
|
|
February 27, 2004
|
|
|
|
4.10
|
|
Amendment No. 1 to Amended & Restated Preferred Stock Rights Agreement, dated as of August 2, 2004, by and between SVB Financial and Wells Fargo Bank, N.A.
|
|
8-A12G/A
|
|
000-15637
|
|
4.13
|
|
August 3, 2004
|
|
|
|
4.11
|
|
Amendment No. 2 to Amended & Restated Preferred Stock Rights Agreement, dated as of January 29, 2008, by and between SVB Financial and Wells Fargo Bank, N.A.
|
|
8-A/A
|
|
000-15637
|
|
4.14
|
|
January 29, 2008
|
|
|
|
4.12
|
|
Amendment No. 3 to Amended and Restated Preferred Stock Rights Agreement, dated as of April 30, 2008, by and between SVB Financial and Wells Fargo Bank, N.A
|
|
8-A/A
|
|
000-15637
|
|
4.20
|
|
April 30, 2008
|
|
|
|
Exhibit
Number
|
|
Exhibit Description
|
|
Incorporated by Reference
|
|
Filed
Herewith
|
||||||
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
|||||
|
4.13
|
|
Amendment No. 4 to Amended and Restated Preferred Stock Rights Agreement, dated as of January 15, 2010, by and between SVB Financial, Wells Fargo Bank, N.A. and American Stock Transfer & Trust Company, LLC
|
|
8-A/A
|
|
000-15637
|
|
4.22
|
|
January 19, 2010
|
|
|
|
4.14
|
|
Indenture, dated September 20, 2010, by and between SVB Financial Group and U.S. Bank National Association, as trustee
|
|
8-K
|
|
000-15637
|
|
4.1
|
|
September 20, 2010
|
|
|
|
4.15
|
|
Form of 5.375% Senior Note due 2020
|
|
8-K
|
|
000-15637
|
|
4.2
|
|
September 20, 2010
|
|
|
|
31.1
|
|
Rule 13a-14(a) / 15(d)-14(a) Certification of Principal Executive Officer
|
|
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
Rule 13a-14(a) / 15(d)-14(a) Certification of Principal Financial Officer
|
|
|
|
|
|
|
|
|
|
X
|
|
32.1
|
|
Section 1350 Certifications
|
|
|
|
|
|
|
|
|
|
**
|
|
101.INS
|
|
XBRL Instance Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
|
|
|
|
|
|
|
|
X
|
|
**
|
Furnished herewith
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
Customers
| Customer name | Ticker |
|---|---|
| Apartment Investment and Management Company | AIV |
| Equity Residential | EQR |
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|